<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD002963" GROUP_ID="PREG" ID="782300022912321740" MERGED_FROM="" MODIFIED="2013-12-06 11:11:50 +0000" MODIFIED_BY="Leanne Jones" REVIEW_NO="0190" REVMAN_SUB_VERSION="5.2.7 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="6.0">
<COVER_SHEET MODIFIED="2013-12-06 11:11:50 +0000" MODIFIED_BY="Leanne Jones">
<TITLE>Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing</TITLE>
<CONTACT MODIFIED="2013-12-06 11:11:50 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="5025" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Kelvin</FIRST_NAME><MIDDLE_INITIALS>H</MIDDLE_INITIALS><LAST_NAME>Tan</LAST_NAME><POSITION>Senior Consultant</POSITION><EMAIL_1>khtan@tan.net</EMAIL_1><EMAIL_2>tan.kok.hian@kkh.com.sg</EMAIL_2><URL>http://tan.net/kh/</URL><ADDRESS><DEPARTMENT>Department of Maternal Fetal Medicine</DEPARTMENT><ORGANISATION>KK Women's and Children's Hospital</ORGANISATION><ADDRESS_1>100 Bukit Timah Road</ADDRESS_1><CITY>Singapore</CITY><ZIP>229899</ZIP><COUNTRY CODE="SG">Singapore</COUNTRY><PHONE_1>+65 2934044 ext: 1011</PHONE_1><PHONE_2>+65 3941011</PHONE_2><FAX_1>+65 8580656</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2013-12-06 11:11:50 +0000" MODIFIED_BY="Leanne Jones"><PERSON ID="5025" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Kelvin</FIRST_NAME><MIDDLE_INITIALS>H</MIDDLE_INITIALS><LAST_NAME>Tan</LAST_NAME><POSITION>Senior Consultant</POSITION><EMAIL_1>khtan@tan.net</EMAIL_1><EMAIL_2>tan.kok.hian@kkh.com.sg</EMAIL_2><URL>http://tan.net/kh/</URL><ADDRESS><DEPARTMENT>Department of Maternal Fetal Medicine</DEPARTMENT><ORGANISATION>KK Women's and Children's Hospital</ORGANISATION><ADDRESS_1>100 Bukit Timah Road</ADDRESS_1><CITY>Singapore</CITY><ZIP>229899</ZIP><COUNTRY CODE="SG">Singapore</COUNTRY><PHONE_1>+65 2934044 ext: 1011</PHONE_1><PHONE_2>+65 3941011</PHONE_2><FAX_1>+65 8580656</FAX_1></ADDRESS></PERSON><PERSON ID="9169" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Rebecca</FIRST_NAME><MIDDLE_INITIALS>MD</MIDDLE_INITIALS><LAST_NAME>Smyth</LAST_NAME><POSITION>Lecturer</POSITION><EMAIL_1>rebecca.smyth@manchester.ac.uk</EMAIL_1><ADDRESS><DEPARTMENT>School of Nursing, Midwifery and Social Work</DEPARTMENT><ORGANISATION>The University of Manchester</ORGANISATION><ADDRESS_1>Jean McFarlane Building</ADDRESS_1><ADDRESS_2>Oxford Road</ADDRESS_2><CITY>Manchester</CITY><ZIP>M13 9PL</ZIP><COUNTRY CODE="GB">UK</COUNTRY><PHONE_1>+44 161 3067739</PHONE_1></ADDRESS></PERSON><PERSON ID="45986340142636670703120626105944" ROLE="AUTHOR"><PREFIX>Mr</PREFIX><FIRST_NAME>Xing</FIRST_NAME><LAST_NAME>Wei</LAST_NAME><POSITION>Research Co-ordinator</POSITION><EMAIL_1>wei.xing@kkh.com.sg</EMAIL_1><ADDRESS><DEPARTMENT>Department of Maternal Fetal Medicine</DEPARTMENT><ORGANISATION>KK Women's and Children's Hospital</ORGANISATION><ADDRESS_1>100 Bukit Timah Road</ADDRESS_1><CITY>Singapore</CITY><ZIP>229899</ZIP><COUNTRY CODE="SG">Singapore</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2013-11-18 22:18:50 +0000" MODIFIED_BY="Jill V Hampson">
<UP_TO_DATE>
<DATE DAY="30" MONTH="9" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="30" MONTH="9" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="30" MONTH="9" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="2001"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2001"/>
</DATES>
<WHATS_NEW MODIFIED="2013-11-18 22:21:24 +0000" MODIFIED_BY="Jill V Hampson">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-11-18 22:19:13 +0000" MODIFIED_BY="Jill V Hampson">
<DATE DAY="30" MONTH="9" YEAR="2013"/>
<DESCRIPTION>
<P>Search updated. Methods updated. </P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2013-11-18 22:21:24 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="30" MONTH="9" YEAR="2013"/>
<DESCRIPTION>
<P>Three new trials (<LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>; <LINK REF="STD-Papadopoulos-2007" TYPE="STUDY">Papadopoulos 2007</LINK>; <LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>) included.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-11-28 11:47:11 +0000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-11-28 11:47:11 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Six reports added to <LINK TAG="AWAITING_STUDIES" TYPE="SECTION">Studies awaiting classification</LINK> (Bolnick 2004; <LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>; <LINK REF="STD-Gonzalez-1998" TYPE="STUDY">Gonzalez 1998</LINK>; <LINK REF="STD-Papadopoulos-2007" TYPE="STUDY">Papadopoulos 2007</LINK>; <LINK REF="STD-Pinette-2005" TYPE="STUDY">Pinette 2005</LINK>; <LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-10-27 09:46:19 +0000" MODIFIED_BY="Jill V Hampson">
<DATE DAY="3" MONTH="11" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-11-03 10:41:32 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="25" MONTH="11" YEAR="2003"/>
<DESCRIPTION>
<P>Two new trials (<LINK REF="STD-Saracoglu-1999" TYPE="STUDY">Saracoglu 1999</LINK> and <LINK REF="STD-Perez_x002d_Delboy-2002" TYPE="STUDY">Perez-Delboy 2002</LINK>) are included but they do not change the conclusions of the review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Department of Maternal Fetal Medicine, KK Women's &amp; Children's Hospital</NAME>
<COUNTRY CODE="SG">Singapore</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES/>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2013-12-03 10:02:52 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2013-10-18 10:13:33 +0100" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2013-10-03 10:21:28 +0100" MODIFIED_BY="[Empty name]">Fetal vibroacoustic stimulation for facilitation of tests of the wellbeing of the unborn baby</TITLE>
<SUMMARY_BODY MODIFIED="2013-10-18 10:13:33 +0100" MODIFIED_BY="[Empty name]">
<P>Acoustic stimulation of unborn babies may make tests on their wellbeing more effective.</P>
<P>Tests on unborn babies such as ultrasound, measuring the number of movements and the heart rate are carried out to check the baby&#8217;s wellbeing. As a baby's sleep periods can alter these results by making it non-reactive, various methods are used to wake the baby so that it can respond to the stimulus. Fetal vibroacoustic stimulation uses a hand-held electronic device placed just above the pregnant woman's abdomen. Brief sounds are sent through the mother&#8217;s abdomen to her baby. The vibroacoustic stimulation gives the opportunity to assess how the baby responds. Exposure of the baby to the vibroacoustic stimulation is generally considered safe but it can cause vigorous fetal movements and fetal distress. </P>
<P>This review of 12 randomised controlled trials involving 6822 mothers found that vibroacoustic stimulation improved the effectiveness of the baby's heart rate testing. However, the data on fetal distress and perinatal death were too few to draw any conclusions on safety. More research is needed to determine the optimal intensity, frequency, duration and position of the vibroacoustic stimulation and to evaluate the safety and perinatal outcomes when used with cardiotocography and other tests of fetal wellbeing.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2013-11-14 10:40:21 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Acoustic stimulation of the fetus has been suggested to improve the efficiency of antepartum fetal heart rate testing. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-10-18 10:15:41 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the advantages and disadvantages of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-10-14 22:34:48 +0100" MODIFIED_BY="Jill V Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2013).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2013-01-16 09:39:37 +0000" MODIFIED_BY="Xing Wei">
<P>All published and unpublished randomised controlled trials assessing the merits of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-01-16 09:38:48 +0000" MODIFIED_BY="Xing Wei">
<P>All review authors independently extracted data and assessed trial quality. Authors of published and unpublished trials were contacted for further information.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2013-11-14 10:40:21 +0000" MODIFIED_BY="[Empty name]">
<P>Altogether 12 trials with a total of 6822 participants were included. Fetal vibroacoustic stimulation reduced the incidence of non-reactive antenatal cardiotocography test (nine trials; average risk ratio (RR) 0.62, 95% confidence interval (CI) 0.48 to 0.81). Vibroacoustic stimulation compared with mock stimulation evoked significantly more fetal movements when used in conjunction with fetal heart rate testing (one trial, RR 0.23, 95% CI 0.18 to 0.29).</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-01-16 09:39:38 +0000" MODIFIED_BY="[Empty name]">
<P>Vibroacoustic stimulation offers benefits by decreasing the incidence of non-reactive cardiotocography and reducing the testing time. Further randomised trials should be encouraged to determine not only the optimum intensity, frequency, duration and position of the vibroacoustic stimulation, but also to evaluate the efficacy, predictive reliability, safety and perinatal outcome of these stimuli with cardiotocography and other tests of fetal wellbeing.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2013-12-03 10:02:52 +0000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2013-11-29 07:48:56 +0000" MODIFIED_BY="Xing Wei">
<P>Antepartum fetal heart rate testing, fetal movement counts, fetal ultrasound examinations and biophysical profile of the fetus are methods of assessing fetal wellbeing. More recently vibroacoustic stimulation of the fetus is performed in conjunction with these tests.</P>
<P>Several studies (<LINK REF="REF-Ingemarsson-1989" TYPE="REFERENCE">Ingemarsson 1989</LINK>; <LINK REF="REF-Keegan-1987" TYPE="REFERENCE">Keegan 1987</LINK>; <LINK REF="REF-Leader-1984" TYPE="REFERENCE">Leader 1984</LINK>; <LINK REF="REF-Smith-1985" TYPE="REFERENCE">Smith 1985</LINK>) have shown that fetal sleeping periods can lead to falsely non-reactive tests, thereby increasing the risk of unnecessary obstetric intervention. Various methods of stimulation have been proposed to arouse the fetus from the sleep cycle or rest-activity cycle. They include a change in maternal position, physical activity, maternal glucose ingestion, sound stimulation, light stimulation and manual fetal manipulation. If the fetus can be aroused sufficiently, such stimulations may be useful when used in conjunction with tests of fetal wellbeing.</P>
<P>Fetal vibroacoustic stimulation was first noted in 1947 by Bernard and Sontag (<LINK REF="REF-Bernard-1947" TYPE="REFERENCE">Bernard 1947</LINK>), who observed that the fetal heart rate accelerated after acoustic stimulation. <LINK REF="REF-Sadovsky-1981" TYPE="REFERENCE">Sadovsky 1981</LINK> correlated fetal movements with fetal wellbeing. In modern obstetrics, vibroacoustic stimulation of the fetus is gained by using a hand-held electronic device placed just above the pregnant woman's abdomen, which transmits brief sound stimuli through the abdominal wall to the fetus.</P>
<P>Antepartum fetal heart rate testing (cardiotocography test) has become a popular method of assessing fetal wellbeing. Acoustic stimulation of the fetus has been suggested to improve the efficiency of antepartum fetal heart rate testing (<LINK REF="REF-Serafini-1984" TYPE="REFERENCE">Serafini 1984</LINK>; <LINK REF="REF-Trudinger-1980" TYPE="REFERENCE">Trudinger 1980</LINK>). By reducing the number of non-reactive cardiotocography secondary to fetal sleep states, the vibroacoustic stimulation test may be expected to reduce maternal and provider anxiety, shorten overall testing time and allow perinatal resources to be better utilised.</P>
<P>Some authors of non-randomised studies (<LINK REF="REF-Nyman-1992" TYPE="REFERENCE">Nyman 1992</LINK>; <LINK REF="REF-Inglis-1993" TYPE="REFERENCE">Inglis 1993</LINK>; <LINK REF="REF-Sarinoglu-1996" TYPE="REFERENCE">Sarinoglu 1996</LINK>) have reported success using fetal vibroacoustic stimulation to improve the efficiency of antepartum fetal heart rate testing without changing the predictive reliability of the tests.</P>
<P>Vibroacoustic stimulation of the human fetus profoundly alters fetal behaviour and heart rate. Fetal vibroacoustic stimulation is a stress in itself and there have been reports of severe fetal distress following vibroacoustic stimulation (<LINK REF="REF-Sherer-1988" TYPE="REFERENCE">Sherer 1988</LINK>; <LINK REF="REF-Sherer-1991" TYPE="REFERENCE">Sherer 1991</LINK>). Vigorous fetal movements evoked by the stimulus may result in tightening of a nuchal cord, bradycardia, and subsequent caesarean section for fetal distress. However, the available information from non-randomised controlled trials suggests that exposure of the fetus to vibroacoustic stimulation is generally clinically safe (<LINK REF="REF-Arulkumaran-1991" TYPE="REFERENCE">Arulkumaran 1991</LINK>; <LINK REF="REF-Arulkumaran-1992" TYPE="REFERENCE">Arulkumaran 1992</LINK>).</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-11-29 07:49:05 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the advantages and disadvantages of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing. In particular, to assess whether the adjunctive use of vibroacoustic stimulation to alter fetal behavioural states leads to less false positive non-reactive tests.</P>
<P>To assess whether the use of fetal vibroacoustic stimulation improves perinatal outcome, leads to greater maternal satisfaction, and is associated with costs savings and a shorter testing time.</P>
</OBJECTIVES>
<METHODS MODIFIED="2013-12-03 10:02:52 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2013-12-03 10:01:56 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2013-01-16 09:39:49 +0000" MODIFIED_BY="[Empty name]">
<P>All published and unpublished randomised controlled trials assessing the merits of the use of fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing. Quasi-randomised trials were excluded.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2013-01-16 09:39:50 +0000" MODIFIED_BY="[Empty name]">
<P>Pregnant women who have an antenatal non-stress cardiotocography test or other tests of fetal wellbeing in conjunction with vibroacoustic stimulation.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-11-29 07:49:05 +0000" MODIFIED_BY="[Empty name]">
<UL>
<LI>Vibroacoustic stimulation versus mock or no stimulation</LI>
<LI>Vibroacoustic stimulation versus mock stimulation</LI>
<LI>Vibroacoustic stimulation versus manual stimulation</LI>
<LI>Vibroacoustic stimulation and cardiotocography versus cardiotocography alone</LI>
<LI>Vibroacoustic stimulation and test of fetal wellbeing versus test of fetal wellbeing alone</LI>
<LI>Vibroacoustic stimulation versus light stimulation</LI>
</UL>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2013-12-03 10:01:56 +0000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2013-12-03 10:01:24 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Reactive cardiotocography</LI>
<LI>Palpated or visualised movements</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2013-12-03 10:01:56 +0000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Testing time for fetal wellbeing</LI>
<LI>Need for contraction stress test</LI>
<LI>Fetal distress</LI>
<LI>Gestation at delivery</LI>
<LI>Operative delivery</LI>
<LI>Perinatal mortality</LI>
<LI>Maternal anxiety</LI>
<LI>Maternal satisfaction</LI>
<LI>Fetal hearing impairment or loss</LI>
<LI>Impaired neurological development</LI>
<LI>Testing time for modified biophysical profile (not prespecified outcome)</LI>
<LI>Non-reassuring biophysical profile (not prespecified outcome)</LI>
</OL>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2013-10-14 22:35:10 +0100" MODIFIED_BY="Jill V Hampson">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (30 September 2013). </P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from: </P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of Embase;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.  </P>
<P>We did not apply any language restrictions.</P>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2013-12-03 10:02:52 +0000" MODIFIED_BY="[Empty name]">
<P>For the methods used when assessing the trials identified in the previous version of this review, <I>see </I>
<LINK REF="REF-Tan-2001" TYPE="REFERENCE">Tan 2001</LINK>.</P>
<P>For this update we used the following methods when assessing the trials identified by the updated search (<LINK REF="STD-Berclaz-1991" TYPE="STUDY">Berclaz 1991</LINK>; <LINK REF="REF-Bolnick-2004" TYPE="REFERENCE">Bolnick 2004</LINK>; <LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>; <LINK REF="STD-Gonzalez-1995" TYPE="STUDY">Gonzalez 1995</LINK>; <LINK REF="STD-Gonzalez-1998" TYPE="STUDY">Gonzalez 1998</LINK>; <LINK REF="STD-Papadopoulos-2007" TYPE="STUDY">Papadopoulos 2007</LINK>; <LINK REF="STD-Pinette-2005" TYPE="STUDY">Pinette 2005</LINK>; <LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>).</P>
<STUDY_SELECTION MODIFIED="2012-12-12 15:20:50 +0000" MODIFIED_BY="[Empty name]">
<P>Three review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2013-11-29 07:49:25 +0000" MODIFIED_BY="[Empty name]">
<P>We designed a form to extract data. For eligible studies, we extracted the data using the agreed form. We resolved discrepancies through discussion. We entered data into Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we planned to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2013-11-29 07:52:02 +0000" MODIFIED_BY="[Empty name]">
<P>We independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved any disagreement by discussion.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>low risk (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal the allocation sequence and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding could not have affected the results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk, high risk or unclear risk for participants;</LI>
<LI>low risk, high risk or unclear risk for personnel;</LI>
<LI>low risk, high risk or unclear risk for outcome assessors.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.  Where sufficient information was reported, or could be supplied by the trial authors, we planned to include missing data in the analyses which we undertook. We assessed methods as:</P>
<UL>
<LI>low risk;</LI>
<LI>high risk;</LI>
<LI>unclear risk.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk (where it is clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review have been reported);</LI>
<LI>high risk (where not all the study&#8217;s pre-specified outcomes have been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other sources of bias</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias.</P>
<P>We assessed whether each study was free of other problems that could put it at risk of bias.</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Cochrane Handbook</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it likely to impact on the findings.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-11-20 09:31:20 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.<I> </I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we used the mean difference if outcomes were measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods. <B> </B>
</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2013-11-29 07:52:10 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>We did not identify any cluster-randomised trials for inclusion. In future updates, if identified and found to be eligible, we will include cluster-randomised trials in the analyses along with individually-randomised trials. We will adjust their<I> </I>sample size<I>s </I>using the methods described in the <I>Cochrane Handbook</I> using an estimate of the intracluster correlation co-efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. If we identify both cluster-randomised trials and individually-randomised trials, we plan to synthesise the relevant information. We will consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely.</P>
<P>We will also acknowledge heterogeneity in the randomisation unit and perform a sensitivity analysis to investigate the effects of the randomisation unit.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Cross-over trials</HEADING>
<P>This is not a valid study design for this review.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-11-29 07:52:19 +0000" MODIFIED_BY="[Empty name]">
<P>For included studies, we noted levels of attrition. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis.</P>
<P>For all outcomes, we carried out analyses, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2013-12-03 10:02:52 +0000" MODIFIED_BY="Jill V Hampson">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if Tau² was greater than zero and either I² was greater than 30% or there was a low P value (less than 0.10) in the Chi² test for heterogeneity.<B> </B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2013-11-29 07:57:54 +0000" MODIFIED_BY="[Empty name]">
<P>Had there been 10 or more studies in the meta-analysis, we planned to investigate reporting biases (such as publication bias) using funnel plots. No meta-analysis included 10 or more studies in this update. In future updates, we will assess funnel plot asymmetry visually.  If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.<I>
<BR/>
</I>
</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2013-11-29 07:52:33 +0000" MODIFIED_BY="Jill V Hampson">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average range of possible treatment effects and we planned to discuss the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials.</P>
<P>If we used random-effects analyses, the results were presented as the average treatment effect with its 95% confidence interval, and the estimates of  Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-12-21 11:25:01 +0000" MODIFIED_BY="[Empty name]">
<P>We did not explore heterogeneity using subgroup analysis. If we identified substantial heterogeneity, we considered whether an overall summary was meaningful, and if it was, used random-effects analysis to produce it.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-11-14 10:50:24 +0000" MODIFIED_BY="Leanne V Jones">
<P>We did not perform sensitivity analyses. In future updates, if more studies are included, we will carry out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates (greater than 20%), or both, with poor-quality (high risk or unclear risk of bias) studies being excluded from the analyses in order to assess whether this makes any difference to the overall result.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2013-12-03 09:58:02 +0000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2013-11-29 07:54:05 +0000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2013-11-18 22:29:39 +0000" MODIFIED_BY="[Empty name]">
<P>A total of 33 trials were identified from the search strategy.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2013-11-29 07:54:05 +0000" MODIFIED_BY="[Empty name]">
<P>Twelve trials were eligible for inclusion. They were conducted in: California, USA (<LINK REF="STD-Smith-1986" TYPE="STUDY">Smith 1986</LINK>); Utah, USA (<LINK REF="STD-Sleutel-1990" TYPE="STUDY">Sleutel 1990</LINK>); New Mexico, USA (<LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>); Western Australia (<LINK REF="STD-Newnham-1990" TYPE="STUDY">Newnham 1990</LINK>); Mexico (<LINK REF="STD-Marquez-1993" TYPE="STUDY">Marquez 1993</LINK>); Thailand (<LINK REF="STD-Tongsong-1994" TYPE="STUDY">Tongsong 1994</LINK>); Greece (<LINK REF="STD-Salamalekis-1995" TYPE="STUDY">Salamalekis 1995</LINK>;<LINK REF="STD-Papadopoulos-2007" TYPE="STUDY">Papadopoulos 2007</LINK>); Colorado, USA (<LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>); Turkey (<LINK REF="STD-Saracoglu-1999" TYPE="STUDY">Saracoglu 1999</LINK>); New York, USA (<LINK REF="STD-Perez_x002d_Delboy-2002" TYPE="STUDY">Perez-Delboy 2002</LINK>); and India (<LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>).</P>
<P>In all the trials, participants in the intervention groups underwent transabdominal acoustic stimulation. In the trial by Marden et al (<LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>), the primary outcome was palpated or visualised fetal movements. For all the other trials, the primary outcome was fetal heart reactivity.</P>
<P>In <LINK REF="STD-Newnham-1990" TYPE="STUDY">Newnham 1990</LINK>, the control group was subjected to manual fetal manipulation if the initial 20-minute trace was not reactive and the test was continued for another 20 minutes. In the remainder of the trials, the control group did not have manual fetal manipulation.</P>
<P>In <LINK REF="STD-Sleutel-1990" TYPE="STUDY">Sleutel 1990</LINK>, in addition to the control group, there were two intervention groups. One intervention group underwent a single five-second transabdominal acoustic stimulation while the other underwent four intermittent three-second transabdominal acoustic stimulations, each stimulus separated by two minutes.</P>
<P>In <LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>, in addition to the control group (no stimulation) and the intervention group (vibroacoustic stimulation), a third group was assigned to receive transabdominal light stimulation.</P>
<P>For further details, <I>see </I>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2013-11-18 22:30:18 +0000" MODIFIED_BY="[Empty name]">
<P>Twenty trials were excluded. For further details, <I>see</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK>. One trial is awaiting translation (<LINK REF="STD-Gonzalez-1995" TYPE="STUDY">Gonzalez 1995</LINK>).</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2013-11-29 14:09:20 +0000" MODIFIED_BY="[Empty name]">
<P>
<I>See </I>
<LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK> for summaries of 'Risk of bias' assessments.</P>
<ALLOCATION MODIFIED="2013-08-22 09:54:29 +0100" MODIFIED_BY="[Empty name]">
<P>All the included trials were randomised but the method of randomisation varied. Three trials (<LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>; <LINK REF="STD-Papadopoulos-2007" TYPE="STUDY">Papadopoulos 2007</LINK>; <LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>) mentioned the use of computer-generated random numbers. Two trials (<LINK REF="STD-Marquez-1993" TYPE="STUDY">Marquez 1993</LINK>; <LINK REF="STD-Smith-1986" TYPE="STUDY">Smith 1986</LINK>) mentioned the use of lottery and <LINK REF="STD-Sleutel-1990" TYPE="STUDY">Sleutel 1990</LINK> used random-number tables. In one trial (<LINK REF="STD-Saracoglu-1999" TYPE="STUDY">Saracoglu 1999</LINK>), the study participants were randomly selected from patients applying to the unit. However, the assignment to acoustic stimulation or non-stress test does not appear to be randomised but women were "divided equally" to interventions. In one trial randomisation was by draw of sealed envelopes (<LINK REF="STD-Newnham-1990" TYPE="STUDY">Newnham 1990</LINK>) and in another randomisation was performed using a statistical package to generate the sequence of assignment (<LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>). The method of randomisation was unknown for the remaining three trials (<LINK REF="STD-Perez_x002d_Delboy-2002" TYPE="STUDY">Perez-Delboy 2002</LINK>; <LINK REF="STD-Salamalekis-1995" TYPE="STUDY">Salamalekis 1995</LINK>; <LINK REF="STD-Tongsong-1994" TYPE="STUDY">Tongsong 1994</LINK>).</P>
<P>Four trials (<LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>; <LINK REF="STD-Marquez-1993" TYPE="STUDY">Marquez 1993</LINK>; <LINK REF="STD-Newnham-1990" TYPE="STUDY">Newnham 1990</LINK>; <LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>) specifically mentioned the use of sealed envelopes. In the remaining trials the method of allocation concealment was unclear.</P>
</ALLOCATION>
<BLINDING MODIFIED="2013-11-29 07:54:37 +0000" MODIFIED_BY="[Empty name]">
<P>The procedure of vibroacoustic stimulation was only blinded in the Marden trial (<LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>) in which stimulation was performed. In the trial of Tongsong (<LINK REF="STD-Tongsong-1994" TYPE="STUDY">Tongsong 1994</LINK>) and of Perez-Delboy (<LINK REF="STD-Perez_x002d_Delboy-2002" TYPE="STUDY">Perez-Delboy 2002</LINK>), all fetal heart rate tracings were interpreted blindly by one independent perinatologist, who did not have clinical information on the group of participants.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2013-11-29 14:09:20 +0000" MODIFIED_BY="Xing Wei">
<P>The risk of incomplete outcome data or attrition bias was low in all studies except <LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>, <LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>, <LINK REF="STD-Marquez-1993" TYPE="STUDY">Marquez 1993</LINK> and <LINK REF="STD-Tongsong-1994" TYPE="STUDY">Tongsong 1994</LINK>. In three studies, the outcome data was not available for some participants. In at least one study (<LINK REF="STD-Bolnick-2006" TYPE="STUDY">Bolnick 2006</LINK>) some women discontinued the trial before completion of non-stress test.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-10-03 08:32:36 +0100" MODIFIED_BY="Xing Wei">
<P>The reporting bias risk was low in most studies. In other cases it is difficult to assess because it was not clear whether there were any unreported findings.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-10-03 08:34:54 +0100" MODIFIED_BY="Xing Wei">
<P>In general the studies included in this review had low or unclear risk of other potential sources of bias.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2013-12-03 09:58:02 +0000" MODIFIED_BY="[Empty name]">
<P>A total of 12 trials with a total of 6822 participants were included. </P>
<SUBSECTION>
<HEADING LEVEL="3">Fetal vibroacoustic stimulation versus mock or no stimulation (nine trials involving 3757 participants)</HEADING>
<P>Fetal acoustic stimulation reduced the incidence of non-reactive cardiotocography in comparison with mock or no acoustic stimulation (nine trials; average risk ratio (RR) 0.62, 95% confidence interval (CI) 0.48 to 0.81; random-effects analysis: Tau² = 0.04; I² = 32% ), <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>.</P>
<P>Fetal acoustic stimulation compared with mock or no stimulation reduced the overall mean cardiotocography testing time (three trials; average mean difference (MD) -6.93 minutes, 95% CI -12.09 minutes to -1.76 minutes; random-effects analysis: Tau² = 19.54; I² = 97%), <LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>.</P>
<P>Three studies suggested that fetal acoustic stimulation reduced the false positive rate (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>), but not the false negative rate (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>) in predicting perinatal morbidity.</P>
<P>The data on fetal distress and perinatal death between the intervention and control groups were too few to draw any inferences. Twenty-five deaths are reported in the five trials that mentioned perinatal mortality. Similarly the data on prediction of fetal distress between the intervention and control groups were too small for any meaningful inference.</P>
<P>Two studies separately reported on non-prespecified outcomes such as mean testing time for modified biophysical profile and incidence of non-reassuring biophysical profile (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK> and <LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>). Fetal vibroacoustic stimulation was found to reduce testing time and incidence of non-reassuring biophysical profile.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Fetal vibroacoustic stimulation versus mock stimulation (two trials involving 791 participants)</HEADING>
<P>Two trials (<LINK REF="STD-Marden-1997" TYPE="STUDY">Marden 1997</LINK>; <LINK REF="STD-Sood-2007" TYPE="STUDY">Sood 2007</LINK>) compared fetal vibroacoustic stimulation with mock stimulation. However, the effect of vibroacoustic stimulation on non-reactive cardiotocography was not statistically significant (two trials, RR 0.80, 95% CI 0.43 to 1.51), <LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>. Vibroacoustic stimulation compared with mock stimulation evoked significantly more fetal movements when used in conjunction with fetal heart rate testing (one trial, RR 0.23, 95% CI 0.18 to 0.29), <LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Fetal vibroacoustic stimulation versus manual stimulation (one trial involving 172 participants)</HEADING>
<P>No differences were detected in the incidence of non-reactive cardiotocography in comparison with manual stimulation of the fetus. <LINK REF="STD-Newnham-1990" TYPE="STUDY">Newnham 1990</LINK> showed no differences in the need for contraction stress test.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intermittent vibroacoustic stimulation versus single vibroacoustic stimulation (one trial involving 60 participants)</HEADING>
<P>The data comparing intermittent versus single stimulation were too small for any meaningful inferences.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Fetal vibroacoustic stimulation versus light stimulation (one trial involving 60 participants)</HEADING>
<P>No differences were detected in the incidence of non-reactive cardiotocography in comparison with light stimulation of the fetus.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2013-10-03 08:51:19 +0100" MODIFIED_BY="[Empty name]">
<P>The benefits of using fetal vibroacoustic stimulation in conjunction with tests of fetal wellbeing must be weighed with respect to its effect on the predictive reliability of the tests and the safety of the procedure.</P>
<P>There is a void in the literature of randomised controlled trials relating to important outcomes such as fetal hearing impairment, impaired neurological development, gestation at delivery, maternal satisfaction and maternal anxiety. These are important safety considerations and aspects relating to hearing loss and possible cochlear damage, stress reaction and perinatal outcome should be further studied in the context of randomised trials before recommendations are made for routine use.</P>
<P>Vibroacoustic stimulation offers a unique opportunity to assess how the fetus responds to the external environment. Vibroacoustic stimulation has other potential advantages in the antepartum assessment of fetal wellbeing and in provoking fetal activity to improve ultrasonic visualisation and diagnosis. Additional prospective investigation is necessary to characterise further how this technique can be more useful clinically.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-11-29 07:55:31 +0000" MODIFIED_BY="Jill V Hampson">
<IMPLICATIONS_PRACTICE MODIFIED="2013-11-29 07:55:27 +0000" MODIFIED_BY="Xing Wei">
<P>By reducing the number of non-reactive cardiotocography secondary to fetal sleep states and reducing the testing time, fetal vibroacoustic stimulation may help perinatal resources to be better utilised. By evoking fetal movements, fetal vibroacoustic stimulation may be useful in ultrasound examination and evaluation of fetal wellbeing.</P>
<P>However, due to the void in the literature of randomised controlled trials relating to important outcomes such as fetal hearing impairment, impairment of neurological development, maternal satisfaction and maternal anxiety, and perinatal mortality, there is still currently insufficient evidence within randomised controlled trials based upon which a firm recommendation regarding the routine use of fetal vibroacoustic stimulation can be made.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-11-29 07:55:31 +0000" MODIFIED_BY="Jill V Hampson">
<P>More randomised studies are needed to define the role of fetal vibroacoustic stimulations in obstetrics. In particular, further randomised trials should be encouraged to determine not only the optimum intensity, frequency, duration and position of the vibroacoustic stimulation, but also to evaluate the efficacy, safety and perinatal outcome of these stimuli in conjunction with cardiotocography and other tests of fetal wellbeing.</P>
<P>Given the large number of excluded studies, future trials should not only be of high quality but need to report outcomes of clinical relevance. There was only one trial in which the comparison was with mock stimulation. It would be good to encourage more blinded studies with mock stimulation to ensure higher quality trials. Trials with outcomes such as fetal hearing impairment, impaired neurological development, maternal satisfaction and maternal anxiety should also be encouraged.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2013-11-29 14:16:14 +0000" MODIFIED_BY="[Empty name]">
<P>Thanks to Professor James Neilson who helped to initiate and conceive this review. </P>
<P>As part of the pre-publication editorial process, this review has been commented on by four peers (an editor and three referees who are external to the editorial team) and the Group's Statistical Adviser.</P>
<P>The National Institute for Health Research (NIHR) is the largest single funder of the Cochrane Pregnancy and Childbirth Group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR, NHS or the Department of Health.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-11-29 14:14:54 +0000" MODIFIED_BY="Xing Wei">
<P>In the update for September 2013, KH Tan, R Smyth and X Wei independently reviewed the new studies and discussed together.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2013-11-14 10:51:32 +0000" MODIFIED_BY="[Empty name]">
<P>Additional comparison added - vibroacoustic stimulation versus light stimulation.</P>
<P>Two new outcomes were added in the 2013 update.</P>
<OL>
<LI>Testing time for modified biophysical profile (not prespecified outcome).</LI>
<LI>Non-reassuring biophysical profile (not prespecified outcome).</LI>
</OL>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2013-11-27 16:34:27 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2013-11-18 22:28:55 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2013-01-16 10:18:06 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Bolnick-2006" MODIFIED="2012-11-02 11:00:21 +0000" MODIFIED_BY="[Empty name]" NAME="Bolnick 2006" YEAR="2006">
<REFERENCE MODIFIED="2012-11-02 11:00:17 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bolnick J, Garcia G, Fletcher B, Rayburn W</AU>
<TI>Cross-over trial of fetal heart rate response to external light and vibroacoustic stimulation [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>191</VL>
<NO>6 Suppl 1</NO>
<PG>S150</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-02 11:00:21 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Bolnick JM, Garcia G, Fletcher BG, Rayburn WF</AU>
<TI>Cross-over trial of fetal heart rate response to halogen light and vibroacoustic stimulation</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2006</YR>
<VL>19</VL>
<NO>4</NO>
<PG>215-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marden-1997" NAME="Marden 1997" YEAR="1997">
<REFERENCE NOTES="&lt;p&gt;Marden D, McDuffie RS Jr, Allen R, Abitz D. A randomized controlled trial of a new fetal acoustic stimulation test for fetal wellbeing. Am J Obstet Gynecol 1997;176:1386-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marden D, McDuffie RS Jr, Allen R, Abitz D</AU>
<TI>A randomized controlled trial of a new fetal acoustic stimulation test for fetal wellbeing</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1997</YR>
<VL>176</VL>
<PG>1386-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Marquez-1993" MODIFIED="2012-11-02 11:01:04 +0000" MODIFIED_BY="Xing Wei" NAME="Marquez 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-11-02 11:01:04 +0000" MODIFIED_BY="Xing Wei" NOTES="&lt;p&gt;Marquez TL, Andrade EH, Goldsmit DM, De La Huerta MIP, Garcia RBL. The value of antepartum fetal heart rate with vibroacoustic stimulation (translation). Ginecol Obstet Mex 1993;61:356-9.&lt;/p&gt;" NOTES_MODIFIED="2012-11-02 11:01:04 +0000" NOTES_MODIFIED_BY="Xing Wei" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Marquez TL, Andrade EH, Goldsmit DM, De La Huerta MIP, Garcia RBL</AU>
<TI>The value of antepartum fetal heart rate with vibroacoustic stimulation</TI>
<SO>Ginecologia y Obstetricia de Mexico</SO>
<YR>1993</YR>
<VL>61</VL>
<PG>356-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Newnham-1990" NAME="Newnham 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Newnham JP, Burns SE, Roberman BD. Effect of vibratory acoustic stimulation on the duration of fetal heart rate monitoring tests. Am J Perinatol 1990;7:232.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Newnham JP, Burns SE, Roberman BD</AU>
<TI>Effect of vibratory acoustic stimulation on the duration of fetal heart rate monitoring tests</TI>
<SO>American Journal of Perinatology</SO>
<YR>1990</YR>
<VL>7</VL>
<PG>232</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Papadopoulos-2007" MODIFIED="2010-04-21 12:00:19 +0100" MODIFIED_BY="[Empty name]" NAME="Papadopoulos 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-04-21 12:00:19 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Papadopoulos VG, Decavalas GO, Kondakis XG, Beratis NG</AU>
<TI>Vibroacoustic stimulation in abnormal biophysical profile: verification of facilitation of fetal well-being</TI>
<SO>Early Human Development</SO>
<YR>2007</YR>
<VL>83</VL>
<NO>3</NO>
<PG>191-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Perez_x002d_Delboy-2002" NAME="Perez-Delboy 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Perez-Delboy A, Weiss J, Michels A, Cleary J, Shevell T, Malone F</AU>
<TI>A randomized trial of vibroacoustic stimulation for antenatal fetal testing [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2002</YR>
<VL>187</VL>
<NO>6 Pt 2</NO>
<PG>S146</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Salamalekis-1995" NAME="Salamalekis 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Salamalekis E, Batalias L, Kassanos D, Loghis C, Pyrgiotis E, Zourlas PA. The acoustic stimulation test and antenatal cardiotocography as diagnostic tools in high risk pregnancies. J Obstet Gynaecol 1995;15:292-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Salamalekis E, Batalias L, Kassanos D, Loghis C, Pyrgiotis E, Zourlas PA</AU>
<TI>The acoustic stimulation test and antenatal cardiotocography as diagnostic tools in high risk pregnancies</TI>
<SO>Journal of Obstetrics and Gynaecology</SO>
<YR>1995</YR>
<VL>15</VL>
<PG>292-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Saracoglu-1999" MODIFIED="2012-11-02 11:00:39 +0000" MODIFIED_BY="[Empty name]" NAME="Saracoglu 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-11-02 11:00:39 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Saracoglu F, Gol K, Sahin I, Turkkani B, Oztopcu C</AU>
<TI>The predictive value of fetal acoustic stimulation</TI>
<SO>Journal of Perinatology</SO>
<YR>1999</YR>
<VL>19</VL>
<PG>103-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Saracoglu F, Gol K, Sahin I, Turkkani T, Atlay C</AU>
<TI>The predictive value of fetal acoustic stimulation</TI>
<SO>Prenatal and Neonatal Medicine</SO>
<YR>1998</YR>
<VL>3 Suppl 1</VL>
<PG>64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sleutel-1990" MODIFIED="2013-01-16 10:18:06 +0000" MODIFIED_BY="Xing Wei" NAME="Sleutel 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-01-16 10:18:06 +0000" MODIFIED_BY="Xing Wei" NOTES="&lt;p&gt;Sleuthel MR. Vibroacoustic stimulation and fetal heart rate in nonstress tests. J Obstet Gynecol Neonat Nurs 1990;19(3):199-204.&lt;/p&gt;" NOTES_MODIFIED="2013-01-16 10:18:06 +0000" NOTES_MODIFIED_BY="Xing Wei" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sleutel MR</AU>
<TI>Vibroacoustic stimulation and fetal heart rate in nonstress tests</TI>
<SO>Journal of Obstetric, Gynecologic and Neonatal Nursing</SO>
<YR>1990</YR>
<VL>19</VL>
<NO>3</NO>
<PG>199-204</PG>
<IDENTIFIERS MODIFIED="2012-09-13 10:34:19 +0100" MODIFIED_BY="Xing Wei"/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1986" NAME="Smith 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Smith CV, Phelan JP, Platt LD, Broussard P, Paul RH. Fetal acoustic stimulation testing. II. A randomized clinical comparison with the nonstress test. Am J Obstet Gynecol 1986;155:131-4.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith CV, Phelan JP, Platt LD, Broussard P, Paul RH</AU>
<TI>Fetal acoustic stimulation testing. II. A randomized clinical comparison with the nonstress test</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1986</YR>
<VL>155</VL>
<PG>131-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sood-2007" MODIFIED="2010-03-02 15:34:13 +0000" MODIFIED_BY="[Empty name]" NAME="Sood 2007" YEAR="2007">
<REFERENCE MODIFIED="2010-03-02 15:34:13 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sood AK</AU>
<TI>Vibroacoustic stimulation and modified fetal biophysical profile in high risk pregnancy</TI>
<SO>Journal of Obstetrics and Gynaecology of India</SO>
<YR>2007</YR>
<VL>57</VL>
<NO>1</NO>
<PG>27-36</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tongsong-1994" NAME="Tongsong 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Tongsong T, Piyamongkol W. Comparison of the acoustic stimulation test with nonstress test. A randomized, controlled clinical trial. J Reprod Med 1994;39:17-20.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tongsong T, Piyamongkol W</AU>
<TI>Comparison of the acoustic stimulation test with nonstress test. A randomized, controlled clinical trial</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1994</YR>
<VL>39</VL>
<PG>17-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2013-11-18 22:28:55 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Berclaz-1991" MODIFIED="2013-01-09 08:45:27 +0000" MODIFIED_BY="Xing Wei" NAME="Berclaz 1991" YEAR="1991">
<REFERENCE MODIFIED="2013-01-09 08:45:27 +0000" MODIFIED_BY="Xing Wei" NOTES="&lt;p&gt;Berclaz G, Herrmann U. Does fetal reaction to vibro-acoustic stimulation depend on its activity state? Gynakologische Rundschau 1991;31(2):89-97&lt;/p&gt;" NOTES_MODIFIED="2013-01-09 08:45:27 +0000" NOTES_MODIFIED_BY="Xing Wei" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Berclaz G, Herrmann U</AU>
<TI>Does fetal reaction to vibro-acoustic stimulation depend on its activity state?</TI>
<SO>Gynakologische Rundschau</SO>
<YR>1991</YR>
<VL>31</VL>
<NO>2</NO>
<PG>89-97</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Devoe-1989" NAME="Devoe 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Devoe LD, Searle NA, Ruedrich DA, Castillo RA, Metheny WP. The effects of vibroacoustic stimulation on baseline heart rate, breathing activity, and body movements of normal term fetuses. Am J Obstet Gynecol 1989;161:524-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Devoe LD, Searle NA, Ruedrich DA, Castillo RA, Metheny WP</AU>
<TI>The effects of vibroacoustic stimulation on baseline heart rate, breathing activity, and body movements of normal term fetuses</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1989</YR>
<VL>161</VL>
<PG>524-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Eller-1992" NAME="Eller 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Eller DP, Robinson LJ, Newman RB. Position of the vibroacoustic stimulator does not affect fetal response. Am J Obstet Gynecol 1992;167:1137-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Eller DP, Robinson LJ, Newman RB</AU>
<TI>Position of the vibroacoustic stimulator does not affect fetal response</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1992</YR>
<VL>167</VL>
<PG>1137-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gagnon-1986" MODIFIED="2012-11-02 11:01:22 +0000" MODIFIED_BY="[Empty name]" NAME="Gagnon 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-11-02 11:01:22 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J. Effects of vibratory acoustic stimulation on human fetal breathing and gross fetal body movements near term. Am J Obstet-Gynecol 1986;155:1227-30.&lt;/p&gt;" NOTES_MODIFIED="2012-11-02 11:01:22 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J</AU>
<TI>Effects of vibratory acoustic stimulation on human fetal breathing and gross fetal body movements near term</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1986</YR>
<VL>155</VL>
<PG>1227-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J. External vibratory acoustic stimulation near term: fetal heart rate and heart rate variability responses. Am J Obstet Gynecol 1987;156:323-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J</AU>
<TI>External vibratory acoustic stimulation near term: fetal heart rate and heart rate variability responses</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1987</YR>
<VL>156</VL>
<PG>323-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gagnon-1987" NAME="Gagnon 1987" YEAR="1987">
<REFERENCE NOTES="&lt;p&gt;Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J. Human fetal responses to vibratory acoustic stimulation from twenty-six weeks to term. Am J Obstet Gynecol 1987;157:1375-81.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J</AU>
<TI>Human fetal responses to vibratory acoustic stimulation from twenty-six weeks to term</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1987</YR>
<VL>157</VL>
<PG>1375-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gagnon-1988" NAME="Gagnon 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J. Fetal heart rate and fetal activity patterns after vibratory acoustic stimulation at thirty to thirty-two weeks' gestational age. Am J Obstet Gynecol 1988;158:75-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gagnon R, Hunse C, Carmichael L, Fellows F, Patrick J</AU>
<TI>Fetal heart rate and fetal activity patterns after vibratory acoustic stimulation at thirty to thirty-two weeks' gestational age</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1988</YR>
<VL>158</VL>
<PG>75-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-1998" MODIFIED="2012-09-21 07:55:00 +0100" MODIFIED_BY="Xing Wei" NAME="Gonzalez 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-09-21 07:55:00 +0100" MODIFIED_BY="Xing Wei" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez Gonzalez NL, Martin JI, Marcos Y, Suarez MN, Laynez E, Jimenez A, et al</AU>
<TI>States of fetal behavior and vibroacoustic stiumulation with an artificial larynx</TI>
<TO>Estados de comportamiento fetal y estimulacion vibroacustica con laringe artificial</TO>
<SO>Progresos de Obstetricia y Ginecologia</SO>
<YR>1998</YR>
<VL>41</VL>
<PG>403-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Groome-1993" MODIFIED="2012-11-02 11:01:31 +0000" MODIFIED_BY="[Empty name]" NAME="Groome 1993" YEAR="1993">
<REFERENCE NOTES="&lt;p&gt;Groome LJ, Bentz LS, Singh KP, Mooney DM. Behavioral state change following vibroacoustic stimulation: effect of the duration of quiet sleep prior to stimulation. Am J Obstet Gynecol 1993;168:296.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Groome LJ, Bentz LS, Singh KP, Mooney DM</AU>
<TI>Behavioral state change following vibroacoustic stimulation: effect of the duration of quiet sleep prior to stimulation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1993</YR>
<VL>168</VL>
<PG>296</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-11-02 11:01:31 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Groome LJ, Bentz LS, Singh KP, Mooney DM. Behavioural state change in normal human fetuses following a single vibroacoustic stimulus: effect of duration of quiet sleep prior to stimulation. Early Hum Dev 1993;33(1):21-7.&lt;/p&gt;" NOTES_MODIFIED="2012-11-02 11:01:31 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Groome LJ, Bentz LS, Singh KP, Mooney DM</AU>
<TI>Behavioural state change in normal human fetuses following a single vibroacoustic stimulus: effect of duration of quiet sleep prior to stimulation</TI>
<SO>Early Human Development</SO>
<YR>1993</YR>
<VL>33</VL>
<NO>1</NO>
<PG>21-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Groome-1994" NAME="Groome 1994" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Groome LJ, Bentz LS, Singh KP</AU>
<TI>Behavioral state organization in human term fetuses: evidence of relatively tight control of state cycling</TI>
<SO>Journal of Maternal-Fetal Medicine</SO>
<YR>1994</YR>
<VL>3</VL>
<PG>49-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hamner-1988" MODIFIED="2009-10-24 21:36:12 +0100" MODIFIED_BY="[Empty name]" NAME="Hamner 1988" YEAR="1988">
<REFERENCE MODIFIED="2009-10-24 21:36:12 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Hamner LH, Latter DK, Mastroianni MA, Grossman JH. Efficacy and safety of fetal acoustic stimulation testing. Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988;Boston, Massachusetts, USA, 1988:2.&lt;/p&gt;" NOTES_MODIFIED="2009-10-24 21:36:12 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hamner LH, Latter DK, Mastroianni MA, Grossman JH</AU>
<TI>Efficacy and safety of fetal acoustic stimulation testing</TI>
<SO>Proceedings of 36th Annual Clinical Meeting of the American College of Obstetricians and Gynecologists; 1988 May 2-5; Boston, Massachusetts, USA</SO>
<YR>1988</YR>
<PG>2</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hasanpour-2013" MODIFIED="2013-11-05 01:09:45 +0000" MODIFIED_BY="Xing Wei" NAME="Hasanpour 2013" YEAR="2013">
<REFERENCE MODIFIED="2013-11-05 01:09:45 +0000" MODIFIED_BY="Xing Wei" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hasanpour S, Raouf S, Shamsalizadeh N, Bani S, Ghojazadeh M, Sheikhan F</AU>
<TI>Evaluation of the effects of acoustic stimulation and feeding mother stimulation on non-reactive non-stress test: a randomized clinical trial</TI>
<SO>Archives of Gynecology and Obstetrics</SO>
<YR>2013</YR>
<VL>287</VL>
<NO>6</NO>
<PG>1105-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kisilevsky-1990" NAME="Kisilevsky 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Kisilevsky BS, Muir DW, Low JA. Maturation of responses elicited by a vibroacoustic stimulus in a group of high-risk fetuses. Maternal-Child Nursing Journal 1990 Fall;19:239-50.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kisilevsky BS, Muir DW, Low JA</AU>
<TI>Maturation of responses elicited by a vibroacoustic stimulus in a group of high-risk fetuses</TI>
<SO>Maternal-Child Nursing Journal</SO>
<YR>1990</YR>
<VL>19</VL>
<PG>239-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kisilevsky-1992" NAME="Kisilevsky 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Kisilevsky BS, Muir DW, Low JA. Maturation of human fetal responses to vibroacoustic stimulation. Child Dev 1992;63:1497-508.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kisilevsky BS, Muir DW, Low JA</AU>
<TI>Maturation of human fetal responses to vibroacoustic stimulation</TI>
<SO>Child Development</SO>
<YR>1992</YR>
<VL>63</VL>
<PG>1497-508</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Maesel-1994" NAME="Maesel 1994" YEAR="1994">
<REFERENCE NOTES="&lt;p&gt;Maesel A, Sladkevicius P, Valentin L, Marsal K. Effect of vibroacoustic stimulation on blood circulation in the middle cerebral and umbilical arteries in healthy term fetuses. J Mat Fetal Invest 1994;4:69-72.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Maesel A, Sladkevicius P, Valentin L, Marsal K</AU>
<TI>Effect of vibroacoustic stimulation on blood circulation in the middle cerebral and umbilical arteries in healthy term fetuses</TI>
<SO>Journal of Maternal Fetal Investigation</SO>
<YR>1994</YR>
<VL>4</VL>
<PG>69-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montan-1992a" MODIFIED="2013-11-18 22:28:55 +0000" MODIFIED_BY="Lynn Hampaon" NAME="Montan 1992a" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Montan S, Arulkumaran S, Ratnam SS. Computerised cardiotocography following vibro-acoustic stimulation. J Perinat Med 1992;20:471-7.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montan S, Arulkumaran S, Ratnam SS</AU>
<TI>Computerised cardiotocography following vibro-acoustic stimulation</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<PG>471-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Montan-1992b" NAME="Montan 1992b" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Montan S, Arulkumaran S, Nyman M, Ratnam SS. Vibro-acoustic stimulation does not alter the duration of high and low fetal heart rate variability episodes. J Perinat Med 1992;20:331-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montan S, Arulkumaran S, Nyman M, Ratnam SS</AU>
<TI>Vibro-acoustic stimulation does not alter the duration of high and low fetal heart rate variability episodes</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<PG>331-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petrovic-1998" NAME="Petrovic 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Petrovic O, Skunca E, Matejcic N. A simplified fetal biophysical profile. Int J Gynecol Obstet 1998;61:9-14.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petrovic O, Skunca E, Matejcic N</AU>
<TI>A simplified fetal biophysical profile</TI>
<SO>International Journal of Gynecology and Obstetrics</SO>
<YR>1998</YR>
<VL>61</VL>
<PG>9-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Pinette-2005" MODIFIED="2010-03-02 16:09:54 +0000" MODIFIED_BY="[Empty name]" NAME="Pinette 2005" YEAR="2005">
<REFERENCE MODIFIED="2010-03-02 16:09:54 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Pinette MG, Blackstone J, Wax JR, Cartin A</AU>
<TI>Using fetal acoustic stimulation to shorten the biophysical profile</TI>
<SO>Journal of Clinical Ultrasound</SO>
<YR>2005</YR>
<VL>33</VL>
<NO>5</NO>
<PG>223-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Schiff-1992" NAME="Schiff 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Schiff E, Lipitz S, Sivan E, Barkai G, Mashiach S. Acoustic stimulation as a diagnostic test: comparison with oxytocin challenge test. J Perinat Med 1992;20:275-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Schiff E, Lipitz S, Sivan E, Barkai G, Mashiach S</AU>
<TI>Acoustic stimulation as a diagnostic test: comparison with oxytocin challenge test</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<PG>275-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Smith-1988" NAME="Smith 1988" YEAR="1988">
<REFERENCE NOTES="&lt;p&gt;Smith CV, Phelan JP, Broussard P, Paul RH. Fetal acoustic stimulation testing. III. Predictive value of a reactive test. J Reprod Med 1988;33:217-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Smith CV, Phelan JP, Broussard P, Paul RH</AU>
<TI>Fetal acoustic stimulation testing. III. Predictive value of a reactive test</TI>
<SO>Journal of Reproductive Medicine</SO>
<YR>1988</YR>
<VL>33</VL>
<PG>217-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-11-05 01:09:45 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Gonzalez-1995" NAME="Gonzalez 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Gonzalez GNL, Parache J, Armas H, Ormazabal JC, Rodriguez PP. Fetal response to vibroacoustic stimulation in basal conditions with low frequency sounds.  Progresos En Obstetricia y Ginecologia 1995;38:374-80&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gonzalez GNL, Parache J, Armas H, Ormazabal JC, Rodriguez PP</AU>
<TI>Fetal response to vibroacoustic stimulation in basal conditions with low frequency sounds</TI>
<SO>Progresos de Obstetricia y Ginecologia</SO>
<YR>1995</YR>
<VL>38</VL>
<PG>374-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</AWAITING_STUDIES>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2013-11-27 16:34:27 +0000" MODIFIED_BY="Jill V Hampson">
<ADDITIONAL_REFERENCES MODIFIED="2013-11-14 11:06:59 +0000" MODIFIED_BY="Jill V Hampson">
<REFERENCE ID="REF-Arulkumaran-1991" MODIFIED="2012-12-12 12:07:37 +0000" MODIFIED_BY="Xing Wei" NAME="Arulkumaran 1991" TYPE="JOURNAL_ARTICLE">
<AU>Arulkumaran S, Skurr B, Tong H, Kek LP, Yeoh KH, Ratnam SS</AU>
<TI>No evidence of hearing loss due to fetal acoustic stimulation test</TI>
<SO>Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>78</VL>
<NO>2</NO>
<PG>283-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Arulkumaran-1992" MODIFIED="2012-12-12 12:07:41 +0000" MODIFIED_BY="Xing Wei" NAME="Arulkumaran 1992" TYPE="JOURNAL_ARTICLE">
<AU>Arulkumaran S, Talbert D, Hsu TS, Chua S, Anandakumar C, Ratnam SS</AU>
<TI>In-utero sound levels when vibroacoustic stimulation is applied to the maternal abdomen: an assessment of the possibility of cochlea damage in the fetus</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1992</YR>
<VL>99</VL>
<NO>1</NO>
<PG>43-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bernard-1947" MODIFIED="2009-11-10 12:46:06 +0000" MODIFIED_BY="Jill V Hampson" NAME="Bernard 1947" TYPE="JOURNAL_ARTICLE">
<AU>Bernard J, Sontag LW</AU>
<TI>Fetal reactivity to acoustic stimulation: a preliminary report</TI>
<SO>Journal of Genetic Psychology</SO>
<YR>1947</YR>
<VL>70</VL>
<PG>205-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Bolnick-2004" MODIFIED="2012-11-02 11:10:47 +0000" MODIFIED_BY="[Empty name]" NAME="Bolnick 2004" TYPE="JOURNAL_ARTICLE">
<AU>Bolnick J, Garcia G, Fletcher B, Rayburn W</AU>
<TI>Cross-over trial of fetal heart rate response to external light and vibroacoustic stimulation [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2004</YR>
<VL>191</VL>
<NO>6 Suppl 1</NO>
<PG>S150</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-11-02 10:56:56 +0000" MODIFIED_BY="Jill V Hampson" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ingemarsson-1989" MODIFIED="2009-11-10 12:46:09 +0000" MODIFIED_BY="Jill V Hampson" NAME="Ingemarsson 1989" TYPE="JOURNAL_ARTICLE">
<AU>Ingemarsson I, Arulkumaran S</AU>
<TI>Reactive fetal heart rate response to vibroacoustic stimulation in fetuses with low scalp blood pH</TI>
<SO>British Journal of Obstetrics and Gynecology</SO>
<YR>1989</YR>
<VL>96</VL>
<PG>562-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Inglis-1993" MODIFIED="2009-11-10 12:46:12 +0000" MODIFIED_BY="Jill V Hampson" NAME="Inglis 1993" TYPE="JOURNAL_ARTICLE">
<AU>Inglis SR, Druzin ML, Wagner WE, Kogut E</AU>
<TI>The use of vibroacoustic stimulation during the abnormal or equivocal biophysical profile</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1993</YR>
<VL>82</VL>
<NO>3</NO>
<PG>371-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Keegan-1987" MODIFIED="2009-11-10 12:46:17 +0000" MODIFIED_BY="Jill V Hampson" NAME="Keegan 1987" TYPE="JOURNAL_ARTICLE">
<AU>Keegan RA</AU>
<TI>The nonstress test</TI>
<SO>Clinical Obstetrics and Gynecology</SO>
<YR>1987</YR>
<VL>30</VL>
<PG>931-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Leader-1984" MODIFIED="2009-11-10 12:46:20 +0000" MODIFIED_BY="Jill V Hampson" NAME="Leader 1984" TYPE="JOURNAL_ARTICLE">
<AU>Leader LR, Baillie P, Martin B, Molteno C, Wynchank S</AU>
<TI>Fetal responses to vibroacoustic stimulation, a possible predictor of fetal and neonatal outcome</TI>
<SO>Australian and New Zealand Journal of Obstetrics and Gynaecology</SO>
<YR>1984</YR>
<VL>24</VL>
<PG>251</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Nyman-1992" MODIFIED="2009-11-10 12:46:22 +0000" MODIFIED_BY="Jill V Hampson" NAME="Nyman 1992" TYPE="JOURNAL_ARTICLE">
<AU>Nyman M, Arulkumaran S, Jakobsson J, Westgren M</AU>
<TI>Vibro-acoustic stimulation in high-risk pregnancies; maternal perception of fetal movements, fetal heart rate and fetal outcome</TI>
<SO>Journal of Perinatal Medicine</SO>
<YR>1992</YR>
<VL>20</VL>
<NO>4</NO>
<PG>267-74</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2013-11-14 10:44:16 +0000" MODIFIED_BY="Jill V Hampson" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sadovsky-1981" NAME="Sadovsky 1981" TYPE="JOURNAL_ARTICLE">
<AU>Sadovsky E</AU>
<TI>Fetal movements and fetal health</TI>
<SO>Seminars in Perinatology</SO>
<YR>1981</YR>
<VL>5</VL>
<PG>131-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sarinoglu-1996" MODIFIED="2009-11-10 12:46:29 +0000" MODIFIED_BY="Jill V Hampson" NAME="Sarinoglu 1996" TYPE="JOURNAL_ARTICLE">
<AU>Sarinoglu C, Dell J, Mercer BM, Sibai BM</AU>
<TI>Fetal startle response observed under ultrasonography: a good predictor of a reassuring biophysical profile</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1996</YR>
<VL>88</VL>
<NO>4 Pt 1</NO>
<PG>599-602</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Serafini-1984" MODIFIED="2009-11-10 12:46:33 +0000" MODIFIED_BY="Jill V Hampson" NAME="Serafini 1984" TYPE="JOURNAL_ARTICLE">
<AU>Serafini P, Lindsay MBJ, Nagey DA, Pupkin MJ. Tseng P, Crenshaw C</AU>
<TI>Antepartum fetal heart rate response to sound stimulation: the acoustic stimulation test</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1984</YR>
<VL>148</VL>
<PG>41</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sherer-1988" MODIFIED="2009-11-10 12:46:35 +0000" MODIFIED_BY="Jill V Hampson" NAME="Sherer 1988" TYPE="JOURNAL_ARTICLE">
<AU>Sherer DM, Menashe M, Sadovsky E</AU>
<TI>Severe fetal bradycardia caused by external vibratory acoustic stimulation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1988</YR>
<VL>159</VL>
<NO>2</NO>
<PG>334-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Sherer-1991" MODIFIED="2009-11-10 12:46:37 +0000" MODIFIED_BY="Jill V Hampson" NAME="Sherer 1991" TYPE="JOURNAL_ARTICLE">
<AU>Sherer DM, Abramowicz JS, Hearn-Stebbins B, Woods JR Jr</AU>
<TI>Sonographic verification of a nuchal cord following a vibratory acoustic stimulation-induced severe variable fetal heart rate deceleration with expedient abdominal delivery</TI>
<SO>American Journal of Perinatology</SO>
<YR>1991</YR>
<VL>8</VL>
<NO>5</NO>
<PG>345-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Smith-1985" NAME="Smith 1985" TYPE="JOURNAL_ARTICLE">
<AU>Smith CV, Phelan JP, Paul RH, Brossard P</AU>
<TI>Fetal acoustic stimulation testing: a retrospective experience with the fetal acoustic stimulation test</TI>
<SO>American Journal of Obstetrics and Gynaecology</SO>
<YR>1985</YR>
<VL>153</VL>
<PG>567-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Trudinger-1980" MODIFIED="2009-11-10 12:46:41 +0000" MODIFIED_BY="Jill V Hampson" NAME="Trudinger 1980" TYPE="JOURNAL_ARTICLE">
<AU>Trudinger BJ, Boylan P</AU>
<TI>Antepartum fetal heart rate monitoring: value of sound stimulation</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1980</YR>
<VL>55</VL>
<PG>265</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2013-11-27 16:34:27 +0000" MODIFIED_BY="Jill V Hampson">
<REFERENCE ID="REF-Neilson-1995" MODIFIED="2009-11-10 12:46:43 +0000" MODIFIED_BY="Jill V Hampson" NAME="Neilson 1995" TYPE="OTHER">
<AU>Neilson JP</AU>
<TI>Fetal vibroacoustic stimulation before labour. [revised 12 May 1994] In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]</TI>
<SO>The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Tan-2001" MODIFIED="2013-11-27 16:34:27 +0000" MODIFIED_BY="[Empty name]" NAME="Tan 2001" TYPE="COCHRANE_REVIEW">
<AU>Tan KH, Smyth RMD</AU>
<TI>Fetal vibroacoustic stimulation for facilitation of tests of fetal wellbeing</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2012-11-20 14:47:28 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-11-20 14:47:28 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD002963"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2009-10-27 09:46:48 +0000" MODIFIED_BY="Jill V Hampson"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2013-11-29 14:04:57 +0000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2013-11-29 14:04:57 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-11-29 07:55:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bolnick-2006">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="[Empty name]">
<P>Computer-generated randomisation schedule.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2010-04-21 07:28:48 +0100" MODIFIED_BY="[Empty name]">
<P>The study population consisted of patients at 33 to 39 weeks of gestation who underwent an NST. Excluded were cases in which the fetus had a cardiac or central nervous system anomaly or had been exposed to a maternal drug that affected the central nervous system or FHR beat-to-beat variability.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-16 09:55:34 +0000" MODIFIED_BY="[Empty name]">
<P>Assigned to receive transabdominal light, vibroacoustic, or no stimulation. The order in which each pregnancy was assigned to receive transabdominal light, vibroacoustic, or no stimulation was determined before the first of the 3 tests according to a computer-generated randomisation schedule. The minimum period between tests was 3 days.The 2 investigators who interpreted each tracing were blinded as to the type of stimulation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:55:45 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity. An adequate FHR acceleration was defined as 15 bpm above baseline for 15 seconds. If it was absent, the stimulus was repeated 10 minutes later up to a maximum of 3 times during the 20-minute NST. Primary endpoints for comparison were the time from the onset of stimulation until the first adequate FHR acceleration and the time before a reactive pattern (2 adequate accelerations).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-11-29 07:55:45 +0000" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-16 10:14:40 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Marden-1997">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomised by sealed envelopes with the use of a statistical package to generate the sequence of assignment.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 09:56:10 +0000" MODIFIED_BY="Xing Wei">
<P>Women of at least 31 weeks' gestation. Inclusion criteria included singleton pregnancy, intact membranes, and no concurrent use of magnesium or narcotics. Country: USA, Colorado. 577 women randomised.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were given acoustic stimulation for 3 seconds with the stimulator placed at the midpoint between the maternal pubic symphysis and umbilicus. Fetal movements were palpated with the other hand at the fundus. Women randomised to control group were given mock stimulation for 3 seconds with the stimulator placed at the midpoint between the maternal pubic symphysis and umbilicus. Fetal movements were palpated with the other hand at the fundus.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-16 10:14:40 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: positive test as defined by palpation or visualisation of fetal movement only by the tester during a vibroacoustic stimulation.<BR/>Other outcome: FHR reactivity.<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="Xing Wei">
<P>The vibratory acoustic stimulus was performed using a vibroacoustic stimulator (Corometrics 146 fetal acoustic stimulator). Randomisation was performed after informed consent.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:56:23 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Marquez-1993">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomised by lottery. Effectiveness of randomisation was assessed by comparisons of several parameters within the two groups which included gestational ages and primary indications.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 09:59:59 +0000" MODIFIED_BY="Xing Wei">
<P>Women of least 32 weeks' gestation. Country: Mexico. 180 women randomised.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-12 12:24:55 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were given acoustic stimulation for 5 seconds.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:56:23 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 accelerations or more of greater than 15 bpm and of 15 seconds duration or more within a 10-minute period.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Stimulus had an audio frequency of 75 Hz and intensity of 74 db and a stimulation duration of 5 seconds. Randomisation was done after informed consent.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:56:31 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Newnham-1990">
<CHAR_METHODS MODIFIED="2013-01-16 10:00:18 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomised by draw of sealed envelopes. Effectiveness of randomisation was assessed by comparisons of several parameters within the 2 groups which included maternal ages, parities, gestational ages and primary indications.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:00:25 +0000" MODIFIED_BY="Xing Wei">
<P>Women of least 34 weeks' gestation. Exclusion criteria - no contraindications to contraction stress tests. Country: Western Australia. 172 women randomised.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-11-27 16:39:31 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were monitored for an initial 5 minutes. If the pattern is non-reactive, a 3-second vibratory acoustic stimulation was applied to the maternal abdomen in the region of the fetal head. The stimulus was repeated a second and a third time, also at 1-minute intervals, if satisfactory FHR accelerations had not occurred.<BR/>Women randomised to non-fetal acoustic stimulation group were monitored for an initial 20 minutes. If the trace was non-reactive, the fetus was stimulated manually and the test was continued for a further 20 minutes. If satisfactory accelerations were not found, the women were then sent for a meal. On her return, a nipple stimulation contraction stress was performed if the subsequent test remained non-reactive after a further 20 minutes.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:56:31 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 accelerations of greater than 15 bpm and of 15 seconds' duration or more within a 20-minute period. In tests in which accelerations had been provoked by fetal acoustic stimulation, the definition of reactivity required 1 of the 2 accelerations to have been unprovoked.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-16 09:41:17 +0000" MODIFIED_BY="Xing Wei">
<P>All tests were performed with Corometrics 115 monitors using Doppler FHR transducers. The tests were performed by specially trained fetal intensive care midwives with a nurse: patient ratio of 1:1. The vibratory acoustic stimulus had an audio frequency of 75 Hz, a sound intensity of 74 db at 1 m in air and a stimulation duration of 3 seconds. Randomisation was performed after informed consent.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:56:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Papadopoulos-2007">
<CHAR_METHODS MODIFIED="2012-10-16 01:54:32 +0100" MODIFIED_BY="[Empty name]">
<P>Randomisation was done with the use of a random number generator in the computer.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-11-27 16:40:54 +0000" MODIFIED_BY="[Empty name]">
<P>The population of the study consisted of patients referred for fetal surveillance to the maternal-fetal medicine department (either on an outpatient basis or after admission to the hospital for various reasons). Inclusion criteria were: singleton pregnancy, gestational age equal or more than 30 weeks + 0 day and BPPS &#8804; 8/10 with a non-reactive NST. Exclusion criteria were: gestational age before 30 weeks, multifetal pregnancy, premature rupture of membranes, known congenital anomalies of the fetus and maternal refuse to participate in the study.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-11-29 07:56:39 +0000" MODIFIED_BY="[Empty name]">
<P>The patients were followed according to department&#8217;s protocol, and biophysical profile was conducted for 30 minutes according to standard criteria. All participants with an abnormal or equivocal BPPS were assigned randomly to 1 of 2 groups. In group A (study group), VAS was applied and, in group B (control group), the observation time was extended. In group A, a 3-second duration stimulus was applied with an artificial larynx placed on maternal abdomen over the fetal vertex. Following VAS, BPPS was reassessed for 30 minutes and if remained non-reassuring a second 3-second stimulus was applied. BPPS was assessed again for another 30 minutes. In group B, we followed the classical method of extended observation time for 60 minutes, divided into 2 periods of 30 minutes each to match the time periods of group A. Participants of both groups with a non-reassuring BPPS at the end of the examination were managed accordingly. BPPS with or more than 8/10 with a reactive NST at any stage was considered indicative of a non-compromised fetus.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-16 10:03:25 +0000" MODIFIED_BY="[Empty name]">
<P>Intrauterine death, caesarean section for fetal distress, Apgar score at 5 minutes, meconium-stained amniotic fluid, admission to NICU for whatever reason.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-04-21 12:00:19 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-01-16 10:16:21 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomisation method unknown.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:16:16 +0000" MODIFIED_BY="Xing Wei">
<P>Women referred to antenatal testing unit for NST.<BR/>Country: New York, USA.<BR/>113 women randomised.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-16 10:16:21 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were given 1 second vibroacoustic stimulation at the maternal abdomen. The stimulus was repeated a second (for 2 seconds) and a third time (for 3 seconds), also at 10-minute intervals, if still not reactive.<BR/>Women randomised to non-fetal acoustic stimulation group were given the traditional NST without the vibroacoustic stimulation.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-16 10:14:51 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2010-04-21 12:06:57 +0100" MODIFIED_BY="[Empty name]"/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:56:50 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Salamalekis-1995">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomisation method unknown. Effectiveness of randomisation was assessed by comparisons of parities. There was no statistical significant difference.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:04:31 +0000" MODIFIED_BY="Xing Wei">
<P>Women of least 37 weeks' gestation with singleton and high risk pregnancies. Country: Greece. 225 women randomised.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-16 10:04:38 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were monitored for at least 5 minutes. A vibratory acoustic stimulation was applied to the maternal abdomen in the region of the fetal head and activated for 1 second 4 consecutive times, with 1 second intervals between stimulations.<BR/>Women randomised to non-fetal acoustic stimulation group were monitored for an initial 20 minutes. If the trace was non-reactive, the test was continued for a further 20 minutes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:56:50 +0000" MODIFIED_BY="Xing Wei">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 accelerations of 15 bpm and of at least 15 seconds' duration or a FHR acceleration of 15 bpm over the baseline for 2 minutes within 5 minutes after acoustic stimulation. Non-reactivity was defined as 40 minutes without a single FHR acceleration of 15 bpm or more, for 15 seconds or more.<BR/>Other outcome: fetal distress within 7 days of test. This was defined by the presence of pathological FHR trace pattern, thick meconium or low Apgar at 5 minutes.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-16 09:41:21 +0000" MODIFIED_BY="Xing Wei">
<P>All tests were performed with Corometrics 115 monitors. The tests were performed 1 hour after a meal in a low noise room with the mother in a semi-recumbent position to minimise the risk of supine hypotension. The vibratory acoustic stimulus was performed using a vibroacoustic stimulator (Corometrics 146 fetal acoustic stimulator), with a sound intensity of 110 db in air. Randomisation after informed consent.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:56:59 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Saracoglu-1999">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:58 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomisation method unknown.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:05:23 +0000" MODIFIED_BY="Xing Wei">
<P>Women seen at Perinatology Unit.<BR/>Country: Turkey.<BR/>400 women randomised.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-16 10:05:28 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were monitored for at least 5 minutes. A vibratory acoustic stimulation was applied to the maternal abdomen in the region of the fetal head and activated for 1 second up to 4 times.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:56:59 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 accelerations of 15 bpm and of at least 15 seconds' duration within a 20-minute period. Non-reactivity was defined as 40 minutes without the reactive criterion.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-11-29 07:56:59 +0000" MODIFIED_BY="[Empty name]">
<P>A fetal acoustic stimulator (Model 146; Corometrics, Wallingford, CT;75 Hz, 74 db) was used, and FHR was recorded with a fetal heart monitor (Model 115; Corometrics).</P>
<P>The report by Saracoglu 1998 only provided data in abstract form and these were inadequate. There was no reply despite various attempts to contact the authors. The abstract was subsequently published in full (<LINK REF="STD-Saracoglu-1999" TYPE="STUDY">Saracoglu 1999</LINK>) and the published paper (<LINK REF="STD-Saracoglu-1999" TYPE="STUDY">Saracoglu 1999</LINK>) is included in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:57:07 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Sleutel-1990">
<CHAR_METHODS MODIFIED="2012-12-12 12:24:58 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomised by means of a random number table.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:16:26 +0000" MODIFIED_BY="[Empty name]">
<P>60 pregnant women at a university hospital who were scheduled for NST. Exclusion criteria were gestational age less than 30 weeks, abnormal FHR, non-reactive NST or a positive contraction at the last antepartum evaluation, mothers who appeared sedated or had used narcotics, sedatives or street drugs within 8 hours and termination of testing on the mother or fetus before completion of NST. Country: USA, Utah.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-16 10:07:49 +0000" MODIFIED_BY="Xing Wei">
<P>They were randomised to 3 groups (control, single stimulation and intermittent stimulation). Women randomised to control group received the traditional NST. Women randomised to the single fetal acoustic stimulation group were given acoustic stimulation for a single 5-second duration with the artificial larynx placed at the maternal abdomen over the fetal head. Women randomised to the intermittent fetal acoustic stimulation group were given acoustic stimulation for 4 3-second duration with the artificial larynx placed at the maternal abdomen over the fetal head. Each stimulus was separated by 2 minutes.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:57:07 +0000" MODIFIED_BY="Xing Wei">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 accelerations of 15 bpm and of at least 15 seconds' duration within a 20-minute period. Non-reactivity was defined as 90 minutes without the reactive criterion.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-01-16 10:15:47 +0000" MODIFIED_BY="Xing Wei">
<P>The vibratory acoustic stimulus was performed using a hand held artificial larynx with a sound pressure level in air of 100 db at 1000 Hz. Randomisation was performed after informed consent.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:57:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Smith-1986">
<CHAR_METHODS MODIFIED="2013-01-16 10:10:48 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomised by lottery. Effectiveness of randomisation was assessed by comparisons of several parameters within the 2 groups which included parities, gestational ages and primary indications.<BR/>It was noted that there was a significantly greater number of postdates women in the non-fetal acoustic stimulation group.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:11:04 +0000" MODIFIED_BY="[Empty name]">
<P>Women of at least 28 weeks' gestation presenting to the Antepartum Fetal Testing Unit of the Hospital. Exclusion criteria - none. Country: USA, California. 715 women randomised.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-01-16 10:15:18 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were monitored for an initial 5 minutes. If the pattern is non-reactive, a 3 second or less vibratory acoustic stimulation was applied to the maternal abdomen in the region of the fetal head. The stimulus was repeated for a maximum of 3 times, at 1-minute intervals, if satisfactory FHR accelerations had not occurred.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:57:13 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 accelerations or more of greater than 15 bpm and of 15 seconds' duration or more within a 10-minute period. Non-reactivity was defined as 40 minutes without 2 qualifying accelerations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="Xing Wei">
<P>All acoustic tests were done with a Model 5C electronic artificial larynx (Western Electric, New York) and performed in the Antepartum Fetal Testing Unit by specially trained nurses with the woman in semi-Fowler's position. Sound pressure levels of this device measured at 1 m in air averaged 82 db, with a fundamental frequency of approximately 80 Hz, and harmonics ranging from 20 to 9000 Hz. Randomisation was done after informed consent.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-27 16:46:43 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sood-2007">
<CHAR_METHODS MODIFIED="2013-11-27 16:46:43 +0000" MODIFIED_BY="[Empty name]">
<P>Randomly allocated by computer-generated random numbers kept in sealed envelopes to either vibroacoustic stimulated modified biophysical profile (VAS/mFBP) or mock stimulation (mFBP).</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:11:54 +0000" MODIFIED_BY="[Empty name]">
<P>214 women with high risk singleton pregnancies detected amongst women attending antenatal clinic. Country: India.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2010-04-21 07:42:59 +0100" MODIFIED_BY="[Empty name]">
<P>Vibroacoustic stimulation was done with EMCO vibroacoustic stimulator (EMCO Health Care Pvt Ltd, Sion, Mumbai, India) with 75 db sound intensity at 1.0 meter and frequency of 75 Hz.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-01-16 10:12:32 +0000" MODIFIED_BY="[Empty name]">
<P>Mean testing time for modified biophysical profile, caesarean section for fetal distress, 5 minute Apgar score &lt; 7, admission to NICU for more than 24 hours.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-11-29 07:57:22 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Tongsong-1994">
<CHAR_METHODS MODIFIED="2013-01-16 10:15:21 +0000" MODIFIED_BY="Xing Wei">
<P>Randomisation: randomisation method unknown. Effectiveness of randomisation was assessed by comparisons of several parameters within the 2 groups which include maternal ages, gestational ages and primary indications. All the FHR tracings were interpreted blindly by 1 independent perinatologist, who did not have any clinical information on the group of women.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-01-16 10:13:00 +0000" MODIFIED_BY="Xing Wei">
<P>Women of least 28 weeks' gestation with indications including postterm pregnancy, intrauterine growth retardation, pregnancy-induced hypertension, chronic hypertension, decreased fetal movement and diabetes mellitus. Country: Thailand. 1273 women randomised.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei">
<P>Women randomised to fetal acoustic stimulation group were given fetal acoustic stimulation for 1 second. If no qualifying acceleration was observed within 15 seconds, the stimulus were repeated up to 3 times. If reactive criteria were not achieved in 10 minutes, a new cycle of stimulation was begun. If both the women in the acoustic stimulation and standard non-acoustic stimulation groups did not meet the reactive criteria within 20 minutes of the tests, the same technique was extended another 20 minutes.<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-11-29 07:57:22 +0000" MODIFIED_BY="[Empty name]">
<P>Primary outcome: FHR reactivity. This was defined by the presence of 2 FHR accelerations or more of greater than 15 bpm and of 15 seconds' duration within a 20-minute period. 1 prolonged acceleration of the FHR of at least 15 bpm lasting more than 2 minutes was also interpreted as reactive. If these criteria were not met in 40 minutes of monitoring, the test was interpreted as non-reactive.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei">
<P>All acoustic tests were performed in the Maternal Fetal Medicine Unit by a specially trained physician with the woman in semi-Fowler's position. Transabdominal acoustic stimulation overlying the fetal vertex was accomplished with an electronic fetal larynx of approximately 80 db and frequency of 80 Hz and a stimulation duration of 1 second. Randomisation was done after informed consent.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>bpm: beats per minute<BR/>BPPS: biophysical profile score<BR/>db: decibels<BR/>FHR: fetal heart rate<BR/>Hz: hertz<BR/>NICU: neonatal intensive care unit<BR/>NST: non-stress test<BR/>VAS: vibroacoustic stimulation<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-11-27 16:54:26 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-11-27 16:53:06 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Berclaz-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-27 16:53:06 +0000" MODIFIED_BY="Xing Wei">
<P>There was a discrepancy between the number of participants presented in figure 3 (n = 18 for sham and n = 16 for real stimulation) and that stated in the text (n = 25). The definition of quiet and active fetuses was not clear. There were 2 types of bars representing <I>tranquille</I> (quiet) fetuses with different shades but no legend was given.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Devoe-1989">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Eller-1992">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei">
<P>Pseudo-randomisation performed using hospital odd or even number. There was a large difference between those given vibroacoustic stimulation over the fetal vertex (n = 115) and over fetal breech (n = 90). There was also discrepancy between the total numbers presented for the results relating to reactive tests (the fetal vertex (n = 96) and over fetal breech (n = 55).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gagnon-1986">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gagnon-1987">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Gagnon-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Gonzalez-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei">
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Groome-1993">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Groome-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Hamner-1988">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data only available in abstract form and were inadequate. There was an unexplained discrepancy between the control (n = 286) and vibroacoustic stimulation (n = 135) groups.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-14 10:38:04 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Hasanpour-2013">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-14 10:38:04 +0000" MODIFIED_BY="Leanne V Jones">
<P>Not eligible as study compared acoustic stimulation and feeding mother stimulation. </P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kisilevsky-1990">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Kisilevsky-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Maesel-1994">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Montan-1992a">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Montan-1992b">
<CHAR_REASON_FOR_EXCLUSION>
<P>Data were not presented or available, or extractable as the specified clinical outcome measures for this review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-01-16 10:17:18 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Petrovic-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-01-16 10:17:18 +0000" MODIFIED_BY="Xing Wei">
<P>The control group (n = 326) was larger than the study group (n = 168). The control group had 2 distinct groups of which 1 group consisted of 158 women with evident fetal activity at the onset after the initial randomisation by schedule and the second group comprised 168 women after randomisation with no distinct fetal heart activity. These 2 distinct groups are analysed together as the control group. Analyses of the results of the 2 groups separately were not available.<BR/>
</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Pinette-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="[Empty name]">
<P>Quasi-randomisation performed using hospital odd or even number.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Schiff-1992">
<CHAR_REASON_FOR_EXCLUSION>
<P>The results of the experimental group were compared to a big group (both experimental and control) and presented. Results relating to the control group alone were not available and not extractable.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-11-27 16:54:26 +0000" MODIFIED_BY="Xing Wei" STUDY_ID="STD-Smith-1988">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-11-27 16:54:26 +0000" MODIFIED_BY="Xing Wei">
<P>The women were randomised but only women delivering within 7 days of a reactive cardiotocograph test were reported. There were 314 women in the control group and only 227 women in the study group. There is also a higher incidence of postdatism in the control group.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-11-18 22:25:49 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<AWAITING_CHAR MODIFIED="2013-11-18 22:25:49 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gonzalez-1995">
<CHAR_METHODS/>
<CHAR_PARTICIPANTS/>
<CHAR_INTERVENTIONS/>
<CHAR_OUTCOMES/>
<CHAR_NOTES MODIFIED="2013-11-18 22:25:49 +0000" MODIFIED_BY="[Empty name]">
<P>Article in Spanish - awaiting translation</P>
</CHAR_NOTES>
</AWAITING_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2013-11-29 14:04:57 +0000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2013-01-16 10:12:36 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bolnick-2006">
<DESCRIPTION>
<P>Computer-generated randomisation schedule.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 09:41:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marden-1997">
<DESCRIPTION>
<P>Randomisation with the use of a statistical package to generate the sequence of assignment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marquez-1993">
<DESCRIPTION>
<P>Random selection.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 09:41:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newnham-1990">
<DESCRIPTION>
<P>Randomisation by draw of sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 10:03:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papadopoulos-2007">
<DESCRIPTION>
<P>Random number generator in the computer.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<DESCRIPTION>
<P>Randomisation method unknown.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Salamalekis-1995">
<DESCRIPTION>
<P>Allocated at random.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:58 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Saracoglu-1999">
<DESCRIPTION>
<P> The study participants were randomly selected from patients applying to the unit. However, the assignment to acoustic stimulation or NST does not appear to be randomised ("divided equally").</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sleutel-1990">
<DESCRIPTION>
<P>Random number table was used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Smith-1986">
<DESCRIPTION>
<P>Randomised by lottery.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 10:12:36 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-2007">
<DESCRIPTION>
<P>Randomised by computer-generated random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 09:41:30 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tongsong-1994">
<DESCRIPTION>
<P>Randomisation method unknown.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-01-09 08:45:27 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bolnick-2006">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marden-1997">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:55 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marquez-1993">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newnham-1990">
<DESCRIPTION>
<P>Sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:56 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Papadopoulos-2007">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="Jill V Hampson" RESULT="UNKNOWN" STUDY_ID="STD-Salamalekis-1995">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:58 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saracoglu-1999">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sleutel-1990">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="Jill V Hampson" RESULT="UNKNOWN" STUDY_ID="STD-Smith-1986">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-2007">
<DESCRIPTION>
<P>Random numbers kept in sealed envelopes.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-11-20 11:44:33 +0000" MODIFIED_BY="Jill V Hampson" RESULT="UNKNOWN" STUDY_ID="STD-Tongsong-1994">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2013-11-29 14:04:39 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-01-16 09:55:51 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bolnick-2006">
<DESCRIPTION>
<P>Not documented if participant or caregiver blinded. 2 outcome investigators who interpreted each tracing were blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-10-03 08:46:19 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marden-1997">
<DESCRIPTION>
<P>By performing the fetal acoustic stimulation test before NST, the tester was blinded to the result of NST.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marquez-1993">
<DESCRIPTION>
<P>Outcome assessor blinded to treatment group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:56 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Newnham-1990">
<DESCRIPTION>
<P>No evidence of blinding.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:56 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Papadopoulos-2007">
<DESCRIPTION>
<P>Not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<DESCRIPTION>
<P>Outcome assessor blinded.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Salamalekis-1995">
<DESCRIPTION>
<P>Not performed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:58 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saracoglu-1999">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sleutel-1990">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-11-29 14:04:26 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Smith-1986">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-11-29 14:04:39 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Sood-2007">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2013-01-16 10:15:30 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tongsong-1994">
<DESCRIPTION>
<P>All the FHR tracings were interpreted blindly by one independent perinatologist, who did not have any clinical information on the group of women.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2013-11-29 14:04:50 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-22 09:41:24 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bolnick-2006">
<DESCRIPTION>
<P>11 cases discontinued the trial before completion of NST and data not analysed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-22 09:41:15 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marden-1997">
<DESCRIPTION>
<P>For 23 women, outcome data were not available. No further information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-12-12 12:24:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marquez-1993">
<DESCRIPTION>
<P>Unable to assess.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:01:12 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newnham-1990">
<DESCRIPTION>
<P>Follow-up 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:03:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papadopoulos-2007">
<DESCRIPTION>
<P>Follow-up: 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:04:21 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<DESCRIPTION>
<P>Follow-up: 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:05:17 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salamalekis-1995">
<DESCRIPTION>
<P>Follow-up: 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:06:07 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saracoglu-1999">
<DESCRIPTION>
<P>Follow-up: 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:10:37 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sleutel-1990">
<DESCRIPTION>
<P>Follow-up: 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-12-12 12:24:59 +0000" MODIFIED_BY="Xing Wei" RESULT="YES" STUDY_ID="STD-Smith-1986">
<DESCRIPTION>
<P>No patients were excluded. Those who refused participation served as a second control group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-01-16 10:12:39 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-2007">
<DESCRIPTION>
<P>Follow-up: 100%.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-11-29 14:04:50 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tongsong-1994">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-11-29 14:04:54 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-04 14:03:15 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bolnick-2006">
<DESCRIPTION>
<P>No outcomes documented in methods section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-07 13:08:02 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marden-1997">
<DESCRIPTION>
<P>No outcomes documented in methods section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marquez-1993">
<DESCRIPTION>
<P>Unable to assess.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-07 14:32:28 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Newnham-1990">
<DESCRIPTION>
<P>No outcomes documented in methods section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-04 15:18:58 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papadopoulos-2007">
<DESCRIPTION>
<P>All outcomes in the methods section have been reported on in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-21 08:39:29 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<DESCRIPTION>
<P>No outcomes documented in methods section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-27 08:02:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salamalekis-1995">
<DESCRIPTION>
<P>All outcomes in the methods section have been reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-07 15:42:33 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Saracoglu-1999">
<DESCRIPTION>
<P>All outcomes in the methods section have been reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 10:10:42 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sleutel-1990">
<DESCRIPTION>
<P>2 hypotheses were stated in the methods section and both were tested.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:25:00 +0000" MODIFIED_BY="Xing Wei" RESULT="YES" STUDY_ID="STD-Smith-1986">
<DESCRIPTION>
<P>All outcomes in the methods section have been reported on.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-04 15:39:56 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-2007">
<DESCRIPTION>
<P>All outcomes in the methods section have been reported on in the results section.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-29 14:04:54 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Tongsong-1994">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2013-11-29 14:04:57 +0000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:54 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bolnick-2006">
<DESCRIPTION>
<P>No evidence of any other form of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-21 08:19:37 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Marden-1997">
<DESCRIPTION>
<P>No evidence of any other form of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:56 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Marquez-1993">
<DESCRIPTION>
<P>Unable to assess.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-21 08:25:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Newnham-1990">
<DESCRIPTION>
<P>No evidence of any other form of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-04 15:19:14 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Papadopoulos-2007">
<DESCRIPTION>
<P>No evidence of any other form of bias. </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-01-16 10:04:23 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Perez_x002d_Delboy-2002">
<DESCRIPTION>
<P>Unable to assess.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:57 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Salamalekis-1995">
<DESCRIPTION>
<P>No evidence of any other form of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-12-12 12:24:58 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Saracoglu-1999">
<DESCRIPTION>
<P>No information provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-09-13 10:20:06 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sleutel-1990">
<DESCRIPTION>
<P>No evidence of any other form of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-29 14:04:30 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Smith-1986">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-03-04 15:39:46 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Sood-2007">
<DESCRIPTION>
<P>No evidence of any other form of bias.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-11-29 14:04:57 +0000" MODIFIED_BY="Leanne V Jones" RESULT="UNKNOWN" STUDY_ID="STD-Tongsong-1994">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2013-11-14 11:07:56 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Fetal vibroacoustic stimulation versus mock or no stimulation</NAME>
<DICH_OUTCOME CHI2="11.685131950637569" CI_END="0.8061755108707468" CI_START="0.4794422822528504" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6217030053234651" ESTIMABLE="YES" EVENTS_1="180" EVENTS_2="299" I2="31.536930573013333" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="-0.09357039851146728" LOG_CI_START="-0.3192636679674614" LOG_EFFECT_SIZE="-0.20641703323946434" METHOD="MH" MODIFIED="2012-11-20 16:07:31 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.16581511762938617" P_Q="1.0" P_Z="3.3690925026474635E-4" Q="0.0" RANDOM="YES" SCALE="10.0" SORT_BY="STUDY" STUDIES="9" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.041888860875833704" TOTALS="YES" TOTAL_1="2414" TOTAL_2="2403" WEIGHT="99.99999999999999" Z="3.5851308452407418">
<NAME>Non reactive cardiotocography test</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.171888679665419" CI_START="0.028776797165142073" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3368375616875298" LOG_CI_START="-1.5409575443434547" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2010-03-02 14:54:55 +0000" MODIFIED_BY="[Empty name]" ORDER="29" O_E="0.0" SE="1.1030261405182866" STUDY_ID="STD-Bolnick-2006" TOTAL_1="60" TOTAL_2="60" VAR="1.2166666666666668" WEIGHT="1.3964971007933604"/>
<DICH_DATA CI_END="2.1216813983551686" CI_START="0.48583898637616957" EFFECT_SIZE="1.0152810152810152" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.32668016876199" LOG_CI_START="-0.3135076379691738" LOG_EFFECT_SIZE="0.006586265396408099" ORDER="53319" O_E="0.0" SE="0.37604948665463755" STUDY_ID="STD-Marden-1997" TOTAL_1="297" TOTAL_2="280" VAR="0.1414132164132164" WEIGHT="9.5883754913974"/>
<DICH_DATA CI_END="1.054130084145453" CI_START="0.08537845694154517" EFFECT_SIZE="0.3" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="10" LOG_CI_END="0.022894207973832136" LOG_CI_START="-1.0686516985345076" LOG_EFFECT_SIZE="-0.5228787452803376" ORDER="53320" O_E="0.0" SE="0.6411794687223782" STUDY_ID="STD-Marquez-1993" TOTAL_1="90" TOTAL_2="90" VAR="0.4111111111111111" WEIGHT="3.8798438280062686"/>
<DICH_DATA CI_END="1.3730139651327375" CI_START="0.004398534830539996" EFFECT_SIZE="0.07771260997067449" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.13767495453409156" LOG_CI_START="-2.3566919646454716" LOG_EFFECT_SIZE="-1.1095085050556899" ORDER="53321" O_E="0.0" SE="1.4652034756414603" STUDY_ID="STD-Perez_x002d_Delboy-2002" TOTAL_1="61" TOTAL_2="52" VAR="2.146821225031815" WEIGHT="0.8030159666723076"/>
<DICH_DATA CI_END="2.3301469142131714" CI_START="0.6126478312701276" EFFECT_SIZE="1.1948051948051948" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="14" LOG_CI_END="0.3673833038674998" LOG_CI_START="-0.21278909952135303" LOG_EFFECT_SIZE="0.07729710217307338" MODIFIED="2012-09-13 07:02:34 +0100" MODIFIED_BY="Xing Wei" ORDER="53322" O_E="0.0" SE="0.34079614165032635" STUDY_ID="STD-Salamalekis-1995" TOTAL_1="110" TOTAL_2="115" VAR="0.11614201016374928" WEIGHT="11.121682325982565"/>
<DICH_DATA CI_END="1.0003768762775629" CI_START="0.37331609614278827" EFFECT_SIZE="0.6111111111111112" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="36" LOG_CI_END="1.6364445278627712E-4" LOG_CI_START="-0.42792328434294824" LOG_EFFECT_SIZE="-0.21387981994508098" ORDER="53323" O_E="0.0" SE="0.2514603810390878" STUDY_ID="STD-Saracoglu-1999" TOTAL_1="200" TOTAL_2="200" VAR="0.06323232323232322" WEIGHT="16.719457265552062"/>
<DICH_DATA CI_END="0.8485384121421633" CI_START="0.49655390522940274" EFFECT_SIZE="0.6491109784053476" ESTIMABLE="YES" EVENTS_1="78" EVENTS_2="122" LOG_CI_END="-0.07132849300006562" LOG_CI_START="-0.3040335981798592" LOG_EFFECT_SIZE="-0.18768104558996243" ORDER="2" O_E="0.0" SE="0.13669213069145916" STUDY_ID="STD-Smith-1986" TOTAL_1="851" TOTAL_2="864" VAR="0.01868473859297095" WEIGHT="29.01543181870357"/>
<DICH_DATA CI_END="1.5254429433275496" CI_START="0.10762961071406138" EFFECT_SIZE="0.4051948051948052" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18339596821479986" LOG_CI_START="-0.9680682305228779" LOG_EFFECT_SIZE="-0.39233613115403904" MODIFIED="2012-09-14 04:03:27 +0100" MODIFIED_BY="Xing Wei" ORDER="41" O_E="0.0" SE="0.6763757701782216" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" VAR="0.45748418248418243" WEIGHT="3.5195515031704763"/>
<DICH_DATA CI_END="0.6951066729562357" CI_START="0.3467480408851279" EFFECT_SIZE="0.49094488188976376" ESTIMABLE="YES" EVENTS_1="43" EVENTS_2="88" LOG_CI_END="-0.15794854228569974" LOG_CI_START="-0.45998598399709123" LOG_EFFECT_SIZE="-0.30896726314139544" ORDER="53325" O_E="0.0" SE="0.17741828837072063" STUDY_ID="STD-Tongsong-1994" TOTAL_1="635" TOTAL_2="638" VAR="0.03147724904839618" WEIGHT="23.956144699721985"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="66.70844070861659" CI_END="-1.7632244515681759" CI_START="-12.093652402988429" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="-6.928438427278302" ESTIMABLE="YES" I2="97.00187865470274" I2_Q="0.0" ID="CMP-001.02" MODIFIED="2013-10-18 10:44:56 +0100" MODIFIED_BY="Xing Wei" NO="2" P_CHI2="3.3306690738754696E-15" P_Q="1.0" P_Z="0.008562942622568268" Q="0.0" RANDOM="YES" SCALE="12.31" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="19.54056127945782" TOTALS="YES" TOTAL_1="1141" TOTAL_2="1154" UNITS="" WEIGHT="100.0" Z="2.6290275389224056">
<NAME>Mean overall fetal heart rate testing time</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_DATA CI_END="-1.3449021735583515" CI_START="-8.655097826441649" EFFECT_SIZE="-5.0" ESTIMABLE="YES" MEAN_1="23.0" MEAN_2="28.0" ORDER="53326" SD_1="13.0" SD_2="12.0" SE="1.864880097426582" STUDY_ID="STD-Marquez-1993" TOTAL_1="90" TOTAL_2="90" WEIGHT="30.172164716996626"/>
<CONT_DATA CI_END="-10.351537409776528" CI_START="-11.58846259022347" EFFECT_SIZE="-10.969999999999999" ESTIMABLE="YES" MEAN_1="18.93" MEAN_2="29.9" MODIFIED="2013-10-18 10:44:56 +0100" MODIFIED_BY="Leanne V Jones" ORDER="53327" SD_1="3.21" SD_2="3.1" SE="0.31554793613649257" STUDY_ID="STD-Saracoglu-1999" TOTAL_1="200" TOTAL_2="200" WEIGHT="35.36193775812648"/>
<CONT_DATA CI_END="-2.939003054708584" CI_START="-6.000996945291414" EFFECT_SIZE="-4.469999999999999" ESTIMABLE="YES" MEAN_1="22.6" MEAN_2="27.07" MODIFIED="2012-09-14 02:50:01 +0100" MODIFIED_BY="Xing Wei" ORDER="53328" SD_1="15.67" SD_2="16.67" SE="0.7811352439982179" STUDY_ID="STD-Smith-1986" TOTAL_1="851" TOTAL_2="864" WEIGHT="34.465897524876894"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.2905657567306429" CI_START="0.17799771114975016" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22742040285899934" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="228" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-0.5367555687689156" LOG_CI_START="-0.7495855821934907" LOG_EFFECT_SIZE="-0.643170575481203" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="Xing Wei" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="2.2573524195785206E-32" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="297" TOTAL_2="280" WEIGHT="100.0" Z="11.845990549690963">
<NAME>Absence of fetal movements by palpation or visualisation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.2905657567306429" CI_START="0.17799771114975016" EFFECT_SIZE="0.22742040285899934" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="228" LOG_CI_END="-0.5367555687689156" LOG_CI_START="-0.7495855821934907" LOG_EFFECT_SIZE="-0.643170575481203" MODIFIED="2012-09-12 09:25:48 +0100" MODIFIED_BY="Xing Wei" ORDER="53333" O_E="0.0" SE="0.1250174034111529" STUDY_ID="STD-Marden-1997" TOTAL_1="297" TOTAL_2="280" VAR="0.015629351155666944" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.30558839832881" CI_END="1.5961686362988934" CI_START="0.6241422094850674" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9981163355893732" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="29" I2="23.40618212600324" I2_Q="100.0" ID="CMP-001.04" LOG_CI_END="0.20307877294523027" LOG_CI_START="-0.20471644596169256" LOG_EFFECT_SIZE="-8.18836508231147E-4" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="Xing Wei" NO="4" P_CHI2="0.2531950807265927" P_Q="0.0" P_Z="0.9937198685824356" Q="8.194473861000983E-37" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="217" TOTAL_2="217" WEIGHT="100.0" Z="0.007871058761607952">
<NAME>Fetal distress within 7 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9273270832719256" CI_START="0.688669785221131" EFFECT_SIZE="1.1520815632965167" ESTIMABLE="YES" EVENTS_1="24" EVENTS_2="22" LOG_CI_END="0.28495542425891535" LOG_CI_START="-0.1619889708836955" LOG_EFFECT_SIZE="0.06148322668760991" ORDER="53334" O_E="0.0" SE="0.26253735011720686" STUDY_ID="STD-Salamalekis-1995" TOTAL_1="107" TOTAL_2="113" VAR="0.06892586020656487" WEIGHT="74.83495653310673"/>
<DICH_DATA CI_END="1.7916966049535692" CI_START="0.1629073728992671" EFFECT_SIZE="0.5402597402597402" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.25326447075588954" LOG_CI_START="-0.7880592598473679" LOG_EFFECT_SIZE="-0.2673973945457392" MODIFIED="2012-09-14 07:35:04 +0100" MODIFIED_BY="Xing Wei" ORDER="42" O_E="0.0" SE="0.6116787139919527" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" VAR="0.3741508491508491" WEIGHT="25.165043466893263"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4681287383891677" CI_END="0.9207382880657399" CI_START="0.26240958801509223" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.4915389657403084" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="27" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="-0.035863796731286236" LOG_CI_START="-0.5810203005998348" LOG_EFFECT_SIZE="-0.3084420486655605" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="Xing Wei" NO="5" P_CHI2="0.4799543972903261" P_Q="1.0" P_Z="0.02656565451519495" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="375" TOTAL_2="372" WEIGHT="100.0" Z="2.2178413076330776">
<NAME>False positive in prediction of fetal distress within 7 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.282660276894111" CI_START="0.2275484687770305" EFFECT_SIZE="1.0963855421686748" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.7228526824995006" LOG_CI_START="-0.6429260826094612" LOG_EFFECT_SIZE="0.03996329994501973" MODIFIED="2012-09-13 07:06:39 +0100" MODIFIED_BY="Xing Wei" ORDER="53335" O_E="0.0" SE="0.8022652073389268" STUDY_ID="STD-Salamalekis-1995" TOTAL_1="83" TOTAL_2="91" VAR="0.6436294629065713" WEIGHT="10.37329391112009"/>
<DICH_DATA CI_END="0.9230395298915661" CI_START="0.2190504226712824" EFFECT_SIZE="0.4496578690127077" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="22" LOG_CI_END="-0.03477969957412706" LOG_CI_START="-0.6594559044870452" LOG_EFFECT_SIZE="-0.3471178020305861" MODIFIED="2012-09-13 09:29:11 +0100" MODIFIED_BY="Xing Wei" ORDER="53336" O_E="0.0" SE="0.3669378949629328" STUDY_ID="STD-Saracoglu-1999" TOTAL_1="186" TOTAL_2="184" VAR="0.1346434187598283" WEIGHT="80.16789591955707"/>
<DICH_DATA CI_END="3.7684803020167683" CI_START="0.008903860308726218" EFFECT_SIZE="0.18317757009345795" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5761662495407315" LOG_CI_START="-2.0504216621981985" LOG_EFFECT_SIZE="-0.7371277063287336" MODIFIED="2012-09-14 04:33:12 +0100" MODIFIED_BY="Xing Wei" ORDER="45" O_E="0.0" SE="1.5428707411753013" STUDY_ID="STD-Sood-2007" TOTAL_1="106" TOTAL_2="97" VAR="2.3804501239748235" WEIGHT="9.458810169322843"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.17275429084143268" CI_END="1.3973839805377075" CI_START="0.4868258198009123" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.824792459896386" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="17" I2="0.0" I2_Q="100.0" ID="CMP-001.06" LOG_CI_END="0.14531576024081277" LOG_CI_START="-0.3126263961369355" LOG_EFFECT_SIZE="-0.08365531794806132" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="Xing Wei" NO="6" P_CHI2="0.9172482672975693" P_Q="0.0" P_Z="0.4739424953570164" Q="1.0646430497659501E-32" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="42" TOTAL_2="45" WEIGHT="100.0" Z="0.7160791292522916">
<NAME>False negative in prediction of fetal distress within 7 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.353581320740187" CI_START="0.4444646150469004" EFFECT_SIZE="0.7756410256410257" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.1314843525245605" LOG_CI_START="-0.3521628086005835" LOG_EFFECT_SIZE="-0.11033922803801151" MODIFIED="2012-09-13 07:12:13 +0100" MODIFIED_BY="Xing Wei" ORDER="53337" O_E="0.0" SE="0.28409673653696854" STUDY_ID="STD-Salamalekis-1995" TOTAL_1="24" TOTAL_2="22" VAR="0.08071095571095573" WEIGHT="80.33206416578241"/>
<DICH_DATA CI_END="7.081826583727114" CI_START="0.18443298964434524" EFFECT_SIZE="1.1428571428571428" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8501452877634503" LOG_CI_START="-0.734161393808077" LOG_EFFECT_SIZE="0.05799194697768673" MODIFIED="2012-09-13 09:32:53 +0100" MODIFIED_BY="Xing Wei" ORDER="53338" O_E="0.0" SE="0.9306295871996703" STUDY_ID="STD-Saracoglu-1999" TOTAL_1="14" TOTAL_2="16" VAR="0.8660714285714286" WEIGHT="11.05424130828288"/>
<DICH_DATA CI_END="6.880969050375465" CI_START="0.11126703148856962" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.8376496044556963" LOG_CI_START="-0.9536334984110698" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2012-09-14 04:41:56 +0100" MODIFIED_BY="Xing Wei" ORDER="46" O_E="0.0" SE="1.0522085616183026" STUDY_ID="STD-Sood-2007" TOTAL_1="4" TOTAL_2="7" VAR="1.1071428571428572" WEIGHT="8.613694525934712"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.9484855932441136" CI_END="2.0958196315895514" CI_START="0.45694266114166526" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9786058449301609" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="13" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.32135390408650744" LOG_CI_START="-0.3401382933920809" LOG_EFFECT_SIZE="-0.009392194652786732" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.622356169934096" P_Q="1.0" P_Z="0.9556149888296318" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1995" TOTAL_2="2112" WEIGHT="100.0" Z="0.05565708356173779">
<NAME>Perinatal deaths</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-03-04 16:20:11 +0000" MODIFIED_BY="[Empty name]" ORDER="173" O_E="0.0" SE="0.0" STUDY_ID="STD-Bolnick-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.998931341734763" CI_START="0.4981869656262563" EFFECT_SIZE="1.222304587760481" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="9" LOG_CI_END="0.47696652302959847" LOG_CI_START="-0.3026076393660403" LOG_EFFECT_SIZE="0.08717944183177914" MODIFIED="2010-04-21 12:23:14 +0100" MODIFIED_BY="[Empty name]" ORDER="36" O_E="0.0" SE="0.4579257219455385" STUDY_ID="STD-Papadopoulos-2007" TOTAL_1="1349" TOTAL_2="1484" VAR="0.2096959668193426" WEIGHT="64.97804571249227"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="53339" O_E="0.0" SE="0.0" STUDY_ID="STD-Salamalekis-1995" TOTAL_1="110" TOTAL_2="115" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.777346770641523" CI_START="0.012993614786507679" EFFECT_SIZE="0.3178928247048138" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8908314633911043" LOG_CI_START="-1.8862700126340568" LOG_EFFECT_SIZE="-0.4977192746214762" ORDER="53340" O_E="0.0" SE="1.6312831538911927" STUDY_ID="STD-Smith-1986" TOTAL_1="366" TOTAL_2="349" VAR="2.6610847281691967" WEIGHT="11.64117795915101"/>
<DICH_DATA CI_END="3.6967131099009096" CI_START="0.10746895909913654" EFFECT_SIZE="0.6303030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5678157476730461" LOG_CI_START="-0.968716957503298" LOG_EFFECT_SIZE="-0.20045060491512595" MODIFIED="2012-09-14 04:16:42 +0100" MODIFIED_BY="Xing Wei" ORDER="43" O_E="0.0" SE="0.9025669169801426" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" VAR="0.8146270396270396" WEIGHT="23.380776328356724"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Impairment of fetal hearing</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-03-04 16:25:29 +0000" MODIFIED_BY="[Empty name]" ORDER="175" O_E="0.0" SE="0.0" STUDY_ID="STD-Bolnick-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="Leanne V Jones" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Impairment of neurological development</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal anxiety</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal satisfaction</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-2.5585401829722896" CI_START="-3.1414598170277097" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.8499999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.12" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="1.0" P_Q="1.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="104" UNITS="" WEIGHT="100.0" Z="19.165240042019523">
<NAME>Mean testing time for modified biophysical profile - not prespecified outcome</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C
ontrol</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.5585401829722896" CI_START="-3.1414598170277097" EFFECT_SIZE="-2.8499999999999996" ESTIMABLE="YES" MEAN_1="4.92" MEAN_2="7.77" MODIFIED="2010-03-02 15:47:17 +0000" MODIFIED_BY="[Empty name]" ORDER="62" SD_1="0.82" SD_2="1.29" SE="0.1487067208003351" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="1.1407817153362563E-30" CI_END="0.9653517369275413" CI_START="0.5238993733567053" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7111590328788252" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="99" I2="99.99999999999999" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="-0.015314417667731239" LOG_CI_START="-0.2807521210173864" LOG_EFFECT_SIZE="-0.14803326934255878" METHOD="MH" MODIFIED="2013-11-14 11:07:19 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.0" P_Q="1.0" P_Z="0.02880652931272978" Q="0.0" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1349" TOTAL_2="1484" WEIGHT="100.0" Z="2.186124071778438">
<NAME>Non-reassuring biophysical profile - not prespecified outcome</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9653517369275415" CI_START="0.5238993733567054" EFFECT_SIZE="0.7111590328788253" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="99" LOG_CI_END="-0.015314417667731138" LOG_CI_START="-0.2807521210173863" LOG_EFFECT_SIZE="-0.14803326934255873" MODIFIED="2010-04-21 12:19:41 +0100" MODIFIED_BY="[Empty name]" ORDER="35" O_E="0.0" SE="0.15591942088540997" STUDY_ID="STD-Papadopoulos-2007" TOTAL_1="1349" TOTAL_2="1484" VAR="0.024310865809241616" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2013-01-16 10:20:36 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Fetal vibroacoustic stimulation versus mock stimulation</NAME>
<DICH_OUTCOME CHI2="1.412159990490929" CI_END="1.5087634684637026" CI_START="0.4262515341838546" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8019431046858667" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="20" I2="29.186493971383797" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.1786211599924697" LOG_CI_START="-0.370334044864236" LOG_EFFECT_SIZE="-0.09585644243588314" METHOD="MH" MODIFIED="2012-09-14 04:18:57 +0100" MODIFIED_BY="Xing Wei" NO="1" P_CHI2="0.23469838515620656" P_Q="1.0" P_Z="0.49367040433984843" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="407" TOTAL_2="384" WEIGHT="100.0" Z="0.6844827162518992">
<NAME>Non reactive cardiotocography test</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.1216813983551686" CI_START="0.48583898637616957" EFFECT_SIZE="1.0152810152810152" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.32668016876199" LOG_CI_START="-0.3135076379691738" LOG_EFFECT_SIZE="0.006586265396408099" ORDER="53341" O_E="0.0" SE="0.37604948665463755" STUDY_ID="STD-Marden-1997" TOTAL_1="297" TOTAL_2="280" VAR="0.1414132164132164" WEIGHT="65.03151406011914"/>
<DICH_DATA CI_END="1.5254429433275496" CI_START="0.10762961071406138" EFFECT_SIZE="0.4051948051948052" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="7" LOG_CI_END="0.18339596821479986" LOG_CI_START="-0.9680682305228779" LOG_EFFECT_SIZE="-0.39233613115403904" MODIFIED="2012-09-14 04:18:57 +0100" MODIFIED_BY="Xing Wei" ORDER="44" O_E="0.0" SE="0.6763757701782216" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" VAR="0.45748418248418243" WEIGHT="34.96848593988087"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.2905657567306429" CI_START="0.17799771114975016" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.22742040285899934" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="228" I2="0.0" I2_Q="0.0" ID="CMP-002.02" LOG_CI_END="-0.5367555687689156" LOG_CI_START="-0.7495855821934907" LOG_EFFECT_SIZE="-0.643170575481203" METHOD="MH" MODIFIED="2012-09-12 09:27:03 +0100" MODIFIED_BY="Xing Wei" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="2.2573524195785206E-32" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="297" TOTAL_2="280" WEIGHT="100.0" Z="11.845990549690963">
<NAME>Absence of fetal movements by palpation or visualisation</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.2905657567306429" CI_START="0.17799771114975016" EFFECT_SIZE="0.22742040285899934" ESTIMABLE="YES" EVENTS_1="55" EVENTS_2="228" LOG_CI_END="-0.5367555687689156" LOG_CI_START="-0.7495855821934907" LOG_EFFECT_SIZE="-0.643170575481203" MODIFIED="2012-09-12 09:27:03 +0100" MODIFIED_BY="Xing Wei" ORDER="53342" O_E="0.0" SE="0.1250174034111529" STUDY_ID="STD-Marden-1997" TOTAL_1="297" TOTAL_2="280" VAR="0.015629351155666944" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-2.5585401829722896" CI_START="-3.1414598170277097" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-2.8499999999999996" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.03" MODIFIED="2013-01-16 10:20:27 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="104" UNITS="" WEIGHT="100.0" Z="19.165240042019523">
<NAME>Mean testing time for modified biophysical profile</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours C
ontrol</GRAPH_LABEL_2>
<CONT_DATA CI_END="-2.5585401829722896" CI_START="-3.1414598170277097" EFFECT_SIZE="-2.8499999999999996" ESTIMABLE="YES" MEAN_1="4.92" MEAN_2="7.77" MODIFIED="2010-03-02 15:53:57 +0000" MODIFIED_BY="[Empty name]" ORDER="63" SD_1="0.82" SD_2="1.29" SE="0.1487067208003351" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" WEIGHT="100.0"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7916966049535696" CI_START="0.16290737289926707" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5402597402597402" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" I2="0.0" I2_Q="0.0" ID="CMP-002.04" LOG_CI_END="0.25326447075588965" LOG_CI_START="-0.7880592598473679" LOG_EFFECT_SIZE="-0.2673973945457392" METHOD="MH" MODIFIED="2012-09-14 07:29:40 +0100" MODIFIED_BY="Xing Wei" NO="4" P_CHI2="1.0" P_Q="1.0" P_Z="0.31413533121749915" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="104" WEIGHT="100.0" Z="1.0065827705009307">
<NAME>Fetal distress within 7 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours 
Treatment
</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours 
Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7916966049535692" CI_START="0.1629073728992671" EFFECT_SIZE="0.5402597402597402" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="7" LOG_CI_END="0.25326447075588954" LOG_CI_START="-0.7880592598473679" LOG_EFFECT_SIZE="-0.2673973945457392" MODIFIED="2012-09-14 04:55:24 +0100" MODIFIED_BY="Xing Wei" ORDER="47" O_E="0.0" SE="0.6116787139919527" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" VAR="0.3741508491508491" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.7684803020167683" CI_START="0.008903860308726218" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.18317757009345795" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.05" LOG_CI_END="0.5761662495407315" LOG_CI_START="-2.0504216621981985" LOG_EFFECT_SIZE="-0.7371277063287336" METHOD="MH" MODIFIED="2012-09-14 07:21:25 +0100" MODIFIED_BY="Xing Wei" NO="5" P_CHI2="1.0" P_Q="1.0" P_Z="0.27129219515002156" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="106" TOTAL_2="97" WEIGHT="99.99999999999999" Z="1.10009168164826">
<NAME>False positive in prediction of fetal distress within 7 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.7684803020167683" CI_START="0.008903860308726218" EFFECT_SIZE="0.18317757009345795" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5761662495407315" LOG_CI_START="-2.0504216621981985" LOG_EFFECT_SIZE="-0.7371277063287336" MODIFIED="2012-09-14 04:58:00 +0100" MODIFIED_BY="Xing Wei" ORDER="48" O_E="0.0" SE="1.5428707411753013" STUDY_ID="STD-Sood-2007" TOTAL_1="106" TOTAL_2="97" VAR="2.3804501239748235" WEIGHT="99.99999999999999"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="6.880969050375462" CI_START="0.11126703148856967" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-002.06" LOG_CI_END="0.837649604455696" LOG_CI_START="-0.9536334984110696" LOG_EFFECT_SIZE="-0.057991946977686754" METHOD="MH" MODIFIED="2012-09-14 07:30:05 +0100" MODIFIED_BY="Xing Wei" NO="6" P_CHI2="1.0" P_Q="1.0" P_Z="0.8990149384880826" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="4" TOTAL_2="7" WEIGHT="100.0" Z="0.1269058221871438">
<NAME>False negative in prediction of fetal distress within 7 days</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="6.880969050375465" CI_START="0.11126703148856962" EFFECT_SIZE="0.875" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.8376496044556963" LOG_CI_START="-0.9536334984110698" LOG_EFFECT_SIZE="-0.057991946977686754" MODIFIED="2012-09-14 07:09:05 +0100" MODIFIED_BY="Xing Wei" ORDER="49" O_E="0.0" SE="1.0522085616183026" STUDY_ID="STD-Sood-2007" TOTAL_1="4" TOTAL_2="7" VAR="1.1071428571428572" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="3.6967131099009105" CI_START="0.10746895909913654" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6303030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-002.07" LOG_CI_END="0.5678157476730462" LOG_CI_START="-0.968716957503298" LOG_EFFECT_SIZE="-0.20045060491512595" METHOD="MH" MODIFIED="2013-01-16 10:20:36 +0000" MODIFIED_BY="Xing Wei" NO="7" P_CHI2="1.0" P_Q="1.0" P_Z="0.6090850725258686" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="110" TOTAL_2="104" WEIGHT="100.0" Z="0.5113798944719826">
<NAME>Perinatal deaths</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimeTreatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Ccontrol</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.6967131099009096" CI_START="0.10746895909913654" EFFECT_SIZE="0.6303030303030303" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5678157476730461" LOG_CI_START="-0.968716957503298" LOG_EFFECT_SIZE="-0.20045060491512595" MODIFIED="2012-09-14 07:31:05 +0100" MODIFIED_BY="Xing Wei" ORDER="99" O_E="0.0" SE="0.9025669169801426" STUDY_ID="STD-Sood-2007" TOTAL_1="110" TOTAL_2="104" VAR="0.8146270396270396" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" NO="3">
<NAME>Fetal vibroacoustic stimulation versus manual stimulation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2061164314500923" CI_START="0.38337923930284634" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.68" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="25" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.08138923408569591" LOG_CI_START="-0.41637140867322325" LOG_EFFECT_SIZE="-0.16749108729376366" METHOD="MH" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.1871646059203986" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="150" WEIGHT="100.0" Z="1.3190134800843447">
<NAME>Non-reactive cardiotocography</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2061164314500923" CI_START="0.38337923930284645" EFFECT_SIZE="0.68" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="25" LOG_CI_END="0.08138923408569591" LOG_CI_START="-0.41637140867322314" LOG_EFFECT_SIZE="-0.16749108729376366" ORDER="53343" O_E="0.0" SE="0.29238706551150884" STUDY_ID="STD-Newnham-1990" TOTAL_1="150" TOTAL_2="150" VAR="0.08549019607843136" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.386288178241403" CI_START="0.10143994748508353" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" I2="0.0" I2_Q="100.0" ID="CMP-003.02" LOG_CI_END="0.1418535197496449" LOG_CI_START="-0.9937909842942071" LOG_EFFECT_SIZE="-0.42596873227228116" METHOD="MH" NO="2" P_CHI2="1.0" P_Q="0.0" P_Z="0.14147369553651398" Q="2.769876773950182E-32" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="150" TOTAL_2="150" WEIGHT="100.0" Z="1.4703252132528566">
<NAME>Need for contraction stress test</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.386288178241403" CI_START="0.10143994748508353" EFFECT_SIZE="0.375" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.1418535197496449" LOG_CI_START="-0.9937909842942071" LOG_EFFECT_SIZE="-0.42596873227228116" ORDER="53344" O_E="0.0" SE="0.6670832032063166" STUDY_ID="STD-Newnham-1990" TOTAL_1="150" TOTAL_2="150" VAR="0.445" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="82" TOTAL_2="90" WEIGHT="0.0" Z="0.0">
<NAME>Perinatal deaths</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="53345" O_E="0.0" SE="0.0" STUDY_ID="STD-Newnham-1990" TOTAL_1="82" TOTAL_2="90" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2012-09-13 10:22:20 +0100" MODIFIED_BY="Xing Wei" NO="4">
<NAME>Intermittent vibroacoustic stimulation versus single vibroacoustic stimulation</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.8749038563471454" CI_START="-1.2749038563471458" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2999999999999998" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2012-09-13 10:22:20 +0100" MODIFIED_BY="Xing Wei" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.7088885162577108" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="22" TOTAL_2="23" UNITS="" WEIGHT="100.00000000000001" Z="0.3733492638247813">
<NAME>Mean testing time for reactive tests</NAME>
<GROUP_LABEL_1>Treatment</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours Treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours Control</GRAPH_LABEL_2>
<CONT_DATA CI_END="1.8749038563471454" CI_START="-1.2749038563471458" EFFECT_SIZE="0.2999999999999998" ESTIMABLE="YES" MEAN_1="4.7" MEAN_2="4.4" MODIFIED="2012-09-13 10:22:20 +0100" MODIFIED_BY="Xing Wei" ORDER="53346" SD_1="2.1" SD_2="3.2" SE="0.8035371408708457" STUDY_ID="STD-Sleutel-1990" TOTAL_1="22" TOTAL_2="23" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-005" MODIFIED="2013-11-14 11:07:56 +0000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Fetal vibroacoustic stimulation versus light stimulation</NAME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.368170063591446" CI_START="0.046570804769315265" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" I2="0.0" I2_Q="0.0" ID="CMP-005.01" LOG_CI_END="0.7298262658251345" LOG_CI_START="-1.3318862571530972" LOG_EFFECT_SIZE="-0.3010299956639812" METHOD="MH" MODIFIED="2012-11-20 14:30:39 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="0.5670866141370015" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="100.0" Z="0.572347447271999">
<NAME>Non-reactive cardiotocography test</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.368170063591449" CI_START="0.046570804769315244" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7298262658251348" LOG_CI_START="-1.3318862571530974" LOG_EFFECT_SIZE="-0.3010299956639812" MODIFIED="2010-03-02 15:07:30 +0000" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="1.2110601416389968" STUDY_ID="STD-Bolnick-2006" TOTAL_1="60" TOTAL_2="60" VAR="1.4666666666666668" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-14 11:07:56 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Perinatal deaths</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-03-04 16:24:26 +0000" MODIFIED_BY="[Empty name]" ORDER="174" O_E="0.0" SE="0.0" STUDY_ID="STD-Bolnick-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-005.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2013-11-14 11:07:56 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="60" TOTAL_2="60" WEIGHT="0.0" Z="0.0">
<NAME>Impairment of fetal hearing</NAME>
<GROUP_LABEL_1>Experimental</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours experimental</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2011-03-04 16:26:33 +0000" MODIFIED_BY="[Empty name]" ORDER="176" O_E="0.0" SE="0.0" STUDY_ID="STD-Bolnick-2006" TOTAL_1="60" TOTAL_2="60" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2013-11-29 14:04:58 +0000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2013-11-29 14:04:58 +0000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAiMAAADnCAMAAAD7EqYIAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2013-11-29 14:04:58 +0000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAT0AAAKCCAIAAAAsjZn3AAAe0klEQVR42u3dsY4dt9nG8QUCBClU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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK/>
<APPENDICES MODIFIED="2013-11-14 10:43:45 +0000" MODIFIED_BY="Jill V Hampson"/>
<EXTENSIONS/>
</COCHRANE_REVIEW>